But I must say it was naïve of me, to think these two worlds wouldn’t overlap.

Motherhood, it turns out, is the ultimate full-time clinical trial — except there’s no ethics committee to keep things in ethical (just your own questionable decision-making at 3 a.m.), no protocol deviations log (though you could keep one for diaper blowouts — I learned this the hard way after scrubbing poop out of a white nursery carpet), and no database lock — because babies never stop generating data, and there’s no cut-off date for queries. And of course, there’s your most important stakeholder — a very demanding little one — whose needs you’re expected to meet immediately and without negotiation.

The similarities hit me fast: the unpredictability, the high stakes, the emotional rollercoaster, the constant balancing act between planning ahead and simply reacting to whatever chaos has just exploded in front of you.

In both roles, you’re trying to keep everything compliant, everyone alive, and yourself at least vaguely sane.

So, here are 10 brutally honest lessons I’ve learned in the past few weeks that prove these two worlds are far more alike than you’d think:

1. Be patient — it’s a marathon, not a sprint

In both motherhood and clinical trials, there’s no fast-forward button. Progress is slow, unpredictable, and often feels like you’re moving backwards before you move forward.

Starting with pregnancy, it’s a game of endless waiting. Those final weeks feel like they drag on forever (and not only because your own feet are out of reach) — every day you think this could be it, and every day… it isn’t. It gets exhausting. By the end, my pilates trainer was asking me every day, “Oh, come on, are you still pregnant?”

But honestly, at this point I thought “well, this might as well have been a sponsor on a weekly call asking, “Do we have any new patients yet?” :D

The tone, the disappointment, oh such a déjà vu — identical.

In trials, you wait for negotiations to start, ethics approvals, patient recruitment, data entry… and then more approvals. In motherhood, you wait for the baby to sleep through the night, to take a proper nap, or to finally master the art of not spitting up five seconds after you’ve put them down. The trick is to accept the pace. You can’t rush enrolment, and you can’t rush a newborn’s milestones, the baby does not care about your agenda — both will happen when they’re good and ready, not a second earlier. The sooner you let go of the idea that you can “speed things up,” the saner you’ll be.

2. Hope for the best, prepare for the worst

(or how both diapers and CRFs can be full of surprises)

In both motherhood and clinical trials, things can look perfectly fine… until you take a closer look. A CRF can appear neat and complete at first glance. Then you spot it: the investigator somehow entered the patient’s weight in kilograms into the height field, or the entire visit date is logged as the year 2098. Similarly, a diaper can seem harmless — until you open it and realise you should have brought hazmat gloves.

You learn quickly that optimism is fine, but blind optimism will get you in trouble. Always double-check and overpack — whether it’s nappies, wipes, and spare clothes, or monitoring tools, spare pens, and backup printouts. And never assume “this will be quick” — because that’s exactly when the patient will show up with an unscheduled visit, or the baby will decide to test the limits of fluid dynamics.

Preparedness is your safety net. In trials, it keeps you from missing a critical point; in motherhood, it keeps you from having to improvise with a muslin cloth and a prayer in the middle of a public meltdown, while a random granny in the elevator judges you for being a bad mom.

3. Manage (lower) your expectations!

(It ain’t like you’ve seen on Instagram — it will suck sometimes, and that’s okay.)

I once saw a reel of a CRA pulling up to a site visit in a Lamborghini, hashtags blazing: #CRAlife #MakeItRain #WorkAndTravel. I nearly choked of laughter.

Reality check: CRAs do not drive Lambos (we prefer Audi 😜); but more likely an SUV where you can fit the entire ISF in the boot. You get my point.

Motherhood has the same illusion problem. No number of perfectly staged reels of glowing moms sipping matcha in coordinated outfits on their “daily walk” will prepare you for the real deal. I’m not saying those days don’t happen — but they are definitely not the norm.

Pregnancy, even an “easy” one, is exhausting and limiting — emotionally and physically. Birth recovery is painful, babies rarely sleep during the night, at least at the beginning, and on a good day it takes roughly 40 minutes just to leave the house for a simple walk at the park. That’s assuming you didn’t forget the wipes, the diapers, or — heaven forbid — the extra bottle of milk.

In both CRA life and motherhood, the highlight reels don’t show the endless logistics, the fatigue, or the small disasters along the way. Lower your expectations, and you’ll find it much easier to appreciate the moments that actually do go smoothly.

4. It will be painful, but also wonderful — let’s not sugarcoat it

Clinical trials are demanding, high-pressure, and, at times, downright exhausting. The timelines are unrealistic, the workload is relentless, and the stakes are enormous. Every missed deadline, every deviation, every delayed patient visit — it all matters. It’s stressful because you’re not just ticking boxes; you’re responsible for data integrity, patient safety, and keeping the whole thing moving despite a hundred moving parts that could (and will) go wrong.

And yet… for me, it’s the most satisfying work I can do. At the end of the day, you’re part of the progress. You’re contributing to something bigger than yourself — changing the future of medicine, shaping pharma innovation, improving patient lives. When you think about that, it’s worth every late night and stressful call. But I get that it’s definitely not for everybody, and that’s okay.

Motherhood is no different. Something that really bothered me early on was that, despite feeling happy and grateful, I also constantly found myself longing for my freedom. I mourned the version of me who could just hop on a plane for a kitesurfing trip, spend hours driving to the sunset in a foreign country, or go on last-minute adventures without planning three days ahead. And here’s the problem — society doesn’t make space for mothers to say this out loud. If you dare to mention it, the reaction is usually, “But this is the ultimate gift, the happiest time of your life! Shame on you, how could you not be overjoyed?!”

Magical experience, my ass. Pregnancy is exhausting. You’re bloated, emotional, unable to put on your own shoes, and by the third trimester, you can barely do anything without help. Birth is scary, recovery is very painful, your body feels foreign, and suddenly your “me time” is measured in minutes.

And yet… having my baby girl has brought me more joy, happiness, and overwhelming love than I could have imagined. I didn’t expect it, and I didn’t think it would hit me this hard — in the best possible way. But here’s the truth: you can hold space for both kinds of emotions. You can love your child fiercely and still miss your old life. We need to normalise that conversation, both in motherhood and in careers that take everything you’ve got.

5. You will make mistakes — and it’s okay

(As long as you don’t sabotage your trial or kill the baby; everything else will pass.)

In clinical trials, mistakes are inevitable. You’ll forget to follow up on that one query, misplace a document in the ISF, or schedule a monitoring visit on a public holiday by accident. You’ll send the wrong version of a consent form to the site once in your career — and trust me, you’ll never do it again.

Motherhood has the same learning curve. You will clip the baby’s skin while trimming their nails (once), you will dress them in a too-warm outfit in August, and you will forget to pack a spare onesie the one time they decide to blow out their diaper in public. And yes — you will Google completely ridiculous things at 2 a.m., like “What is a normal body temperature for newborns?”

The key in both worlds is this: most mistakes are not fatal, they are lessons. In trials, you document them, correct them, and move on. In motherhood, you cry a little, laugh a little, maybe eat something sweet, and try again tomorrow.

Perfection is not the goal — survival, progress, and keeping the truly catastrophic errors at zero is. Everything else is just part of the learning curve.The unexpected most certainly will happen.

6. The unexpected will happen

If there’s one universal truth, it’s that nothing ever goes exactly as planned. In clinical trials, that could mean patients dropping out minutes before dosing, the courier misplacing your lab samples, or the sponsor deciding to “just” add another amendment halfway through the study. Sometimes it’s the site calling with an urgent safety report while you’re mid–monitoring visit at a completely different location, or a sudden protocol clarification that flips half your data into “to be reverified” mode.

In motherhood, it’s the same chaos in a different costume. A sudden fever at 2 a.m., a diaper blowout precisely five minutes before you need to leave, a nap boycott on the one day you really needed some peace, or the baby discovering a brand-new, high-pitched scream and deciding to test it in public.

Both roles force you to become part detective, part firefighter, part juggler. You learn to think on your feet, adjust your plan in real time, and improvise without showing how close you are to swearing under your breath. The unexpected isn’t a rare emergency — it’s the default setting. The sooner you accept that, the less energy you waste being shocked by it.

7. Your team is your lifeline

(Crucial for keeping your sanity.)

When I was a junior CRA, I had this idea that I was the “main character.” I was cocky, convinced I could do everything better myself, and significantly underestimated the importance of working in a team.

Man, I was such an asshole.

It took a few valuable lessons — and a couple of near disasters — to realise that without my team (IHCRAs, coordinators, PMs, LCRAs), I was completely lost. It took me even longer to learn to ask for help. At this point in my career, I can say with full confidence: your team is everything. They’re the make-or-break factor. This is one of the main reasons I’m so happy at Cromos — I genuinely enjoy working with the people here, and that makes all the difference.

Parenthood is no different. Your partner becomes your lifeline. No, it won’t always be 50–50 — we, as mothers, do tend to take on more of the childcare responsibilities — but having a loving, caring husband is priceless. The one who preps everything for your “night shift” with the baby, who takes the baby in the early morning so you can get a bit more sleep, and who devotes evenings and weekends to the family so you can finally put your feet up.

In those moments, I’m reminded exactly why I married my guy. 😉 So choose your teammates wisely, it goes long way.

8. Things will not always happen on your timeline

So leave room for error — and yes, error will happen. See point 6.

As I mentioned above, the baby does not care about your agenda. It’s not like you can send her a meeting invite and get a polite acceptance. You may have perfectly laid plans — “We’ll feed at 6, nap at 7, leave the house by 8” — but so does she. And her plan may involve a 45-minute screaming protest right when you’re just out the door.

In motherhood, flexibility is survival. You learn to leave room for delays, setbacks, and full-on derailments, because they will happen. You prepare in advance — extra snacks, extra clothes, extra time — and you stop expecting the day to go exactly as you pictured.

The same is true in CRA life. This job is extremely dynamic, and “fires” erupt all the time — a site calls with an urgent safety issue, a patient drops out last minute, or an urgent RFI from the sponsor lands in your inbox at 5:45 p.m. This is why I believe CRAs shouldn’t be booked to 100% capacity. If you’re maxed out, there’s no room to absorb emergencies or last-minute changes, and that’s when everything starts to unravel. A good CRA schedule has buffer built in — not because you’re slacking, but because reality will eat your perfect plan for breakfast.

In both worlds, the key is to plan well, but hold those plans loosely. Leave space for the unexpected, and you’ll avoid the complete disaster that comes from being caught with no wiggle room.

9. Keep calm — everything will be alright

In both clinical trials and motherhood, panic is your worst enemy. Yes, some situations feel urgent, dramatic, and like the world might collapse if you don’t fix them right now. But in most cases, a deep breath and a clear head will get you much further than frantic scrambling.

In CRA life, you quickly learn that not every “urgent” email is truly urgent. The PI can’t find the lab report? It’s probably filed under the wrong tab. The sponsor is worried about a missed visit? There’s usually a logical explanation — and a documented one, if you’re doing your job right. Nine times out of ten, the problem isn’t a catastrophe, it’s just noise.

Motherhood teaches you the same. The baby’s crying? Sometimes it’s hunger, sometimes it’s gas, sometimes it’s… nothing in particular. You don’t need to solve it in the next 30 seconds to be a good mom. Most things will pass on their own — and the ones that don’t, you’ll handle better if you’re not in fight-or-flight mode.

So as long as no one dies — you’re good.

The real skill is learning to assess before reacting, to choose where to spend your emotional energy, and to remind yourself that this too shall pass. Whether it’s a stubborn site or a sleepless night, staying calm won’t fix the problem instantly — but it will keep you sane long enough to find the solution.

10. Bonus tip — enjoy the small wins and the little moments

The last thing I realised is that the time moves faster than you think. In CRA life, you’ll never have your first on-site visit again. You’ll never randomise your very first patient again. You’ll never pass your first audit or get that first approved IMP for the first time again. Those moments are one-time milestones, and they deserve to be noticed before they’re gone.

Motherhood is the same. You’ll never have your first baby again. You’ll never relive those first newborn cuddles, the first playful giggles, the first bleary-eyed night feeds, or that first independent stroller walk in the park, after a painful recovery from birth. They might not always feel magical in the moment — especially if you’re tired, stressed, or juggling a hundred other things — but they are moments you’ll look back on with a smile.

As crazy, chaotic, and unpredictable as it all gets, you might as well enjoy it. These experiences — in trials and in life — will never repeat.

This article was inspired by many people who want to start their career in clinical trials or switch from a different field, but don't have the slightest idea what we actually do. I understand that clinical trials can be an overwhelming concept, especially when you're searching and applying for jobs without really understanding what the job titles and descriptions mean.

So I'm here to help you out and give you some hints.

First, it matters whether you're going to work for a pharmaceutical/biotech company (we call them sponsors), a CRO (Clinical Research Organization), or a clinical trial site. While there are many more niche jobs, for the purpose of this article, I'll keep it simple and review the different job options in these three main categories.

Jobs in a Pharmaceutical or Biotech Company (Sponsor)

Sponsor companies develop new drugs and medical devices and oversee the entire clinical trial process, from early research to market approval. These include companies like Pfizer, UroGen, AstraZeneca, and Bristol-Myers Squibb, Actavis (previously a major pharmaceutical company in Bulgaria is now integrated into Teva, a global generics giant) etc.

Research & Development (R&D) – “The Inventors”

What they do: These scientists discover new medicines and test them in laboratories before human trials. They study how drugs work and evaluate their safety prior to the first human tests.

Key Jobs in R&D:

Preclinical Research Scientist – Tests new drugs on cells or animals in laboratory settings before human trials.

Translational Medicine Scientist – Bridges the gap between lab research and human trials, ensuring drugs are suitable for human testing.

Example: When a company discovers a new cancer drug, R&D scientists test it in the lab to verify it can safely eliminate cancer cells.

Clinical Development & Operations – “The Trial Conductors”

What they do: This team plans and runs clinical trials (human studies) to test the effectiveness of new drugs. They ensure studies are conducted correctly, on time, and within budget.

Key Jobs in Clinical Development:

Clinical Scientist – Helps design the study plan (protocol) and analyzes trial results to evaluate drug effectiveness.

Clinical Trial Manager (CTM) – Oversees the entire trial process, coordinating all aspects to ensure smooth operation.

Clinical Research Associate (CRA, that is me) – Visits hospitals and clinics to monitor the study and ensure protocol compliance. This role exists in both sponsor companies and CROs. While I've worked exclusively in CROs, the core responsibilities remain similar across both settings, with some minor differences.

Medical Science Liaison (MSL) – Works closely with doctors and scientists to explain how a new drug works.

Example: If a company wants to test a new asthma inhaler, the CTM organizes the trial, the CRA visits hospitals to check if the study is done correctly, and the Clinical Scientist analyzes the results.

Regulatory Affairs – “The Rule Keepers”

What they do: These experts make sure all trials and medicines follow the laws and safety rules set by health authorities like the FDA (USA) or EMA (Europe). Without them, companies cannot get drug approval. And may we all say Amen for the RA specialists! Having gotten my hands dirty with a decent amount of regulatory work, I can tell you it's complicated, messy, and extremely precise. It's time- and energy-consuming, requiring you to stay constantly on top of your game with all regulation updates. With complete honesty, this is my least favorite work in the clinical trial scope—I personally find it very challenging.

Key Jobs in Regulatory Affairs:

Regulatory Affairs Associate – Prepares and submits documentation to FDA, EMA, or other agencies for clinical trial approvals.

Regulatory Strategy Lead – Develops strategic plans for efficient drug approval while ensuring full regulatory compliance.

Example: When a company develops a new painkiller, regulatory affairs teams must secure approval both for initial human testing and eventual market release.

Data Management & Biostatistics – "The Number Crunchers"

What they do: They collect, organize, and analyze trial data to ensure accurate and unbiased results. They're also the ones who keep raising queries in your otherwise perfectly clean EDC data (just kidding, DM team — you know I love you).

Key Jobs in Data Management:

Data Manager – Ensures all study information is collected and stored accurately.

Biostatistician – Applies statistical analysis to determine drug effectiveness compared to placebo.

Example: When a study collects 10,000 blood pressure readings, the data manager ensures proper data organization, while the biostatistician analyzes whether the new drug is more effective than existing treatments.

Safety & Pharmacovigilance – "The Drug Safety Guards"

What they do: This team tracks and reports side effects of medicines during trials and after market approval.

Key Jobs in Safety & Pharmacovigilance:

Drug Safety Associate – Collects and reports side effects to health authorities.

Risk Management Specialist – Develops safety plans to reduce risks when a drug enters the market.

Example: When a new diabetes drug causes nausea, the Drug Safety Associate reports it, and the Risk Management Specialist creates strategies to minimize nausea for patients.

Medical Affairs & Medical Writing – "The Science Communicators"

What they do: They explain trial results and drug information to doctors, regulators, and the public.

Key Jobs in Medical Affairs & Writing:

Medical Science Liaison (MSL) – Educates doctors and researchers about new medicines.

Medical Writer – Creates scientific reports, drug labels, and journal articles.

Example: When a new migraine drug is approved, the Medical Writer prepares a comprehensive report for doctors, and the MSL guides them on safe usage.

Quality & Compliance – "The Trial Police"

What they do: They ensure trials follow Good Clinical Practice (GCP) rules to protect patients and guarantee accurate results.

Key Jobs in Quality & Compliance:

Quality Assurance Specialist – Verifies that trials follow legal and ethical guidelines.

Audit & Compliance Manager – Performs inspections to ensure proper clinical trial documentation.

Example: During a hospital inspection, the Quality Assurance team verifies that all patient records and data are properly maintained.

Jobs in a Contract Research Organization (CRO)

CROs conduct clinical trials on behalf of sponsors, handling study setup, monitoring, and regulatory compliance. They don’t invent the drugs, but they organize, monitor, and ensure that trials follow the rules. These include companies like Cromos Pharma, IQVIA, ICON, PSI, PPD etc.

Many roles in a CRO overlap with those in a sponsor company, but they focus more on the actual trial execution. CROs build close relationships with sponsor companies and provide regular updates on study progress. To secure a clinical trial, CROs participate in a bidding process, submit proposals to sponsors, and if successful, are awarded the study.

Clinical Operations & Monitoring – "The Trial Supervisors"

This team ensures clinical trials are conducted correctly. They verify that hospitals and clinics follow the study plan, treat patients safely, and record all information properly.

Key Jobs in Clinical Operations:

Clinical Research Associate (CRA, yey me again) – Visits hospitals and research sites to monitor the trial. They verify protocol compliance and data accuracy. And yes, we're the ones who keep track of every PI's numerous passwords, including email!

Example: If a trial is testing a new diabetes drug, the CRA visits hospitals to check if patients are getting the correct dose and if doctors are reporting any side effects properly.

How this role is different in a CRO vs. a Sponsor?

• In a CRO, CRAs usually monitor multiple studies for different sponsor companies.

• In a sponsor company, CRAs often focus on one or a few trials that the company is directly funding.

Project Manager (PM) – Manages the entire study, ensuring timelines, budgets, and tasks stay on track. This is the equivalent of a clinical trial manager in a sponsor company.

Example: If a trial is supposed to last one year but patient enrollment is too slow, the PM works with different teams to find solutions and speed up recruitment.

Clinical Trial Assistant (CTA) – Supports CRAs and project managers by organizing documents and reports.

Example: If a hospital in the study needs to update its consent forms, the CTA ensures the newest version is sent and stored properly.

Regulatory & Start-Up – "The Rule Followers"

Similar to the sponsors' RA team, this team ensures the trial follows government laws. They secure approvals from ethics committees and regulatory agencies before the study starts.

Key Jobs in Regulatory & Start-Up:

Regulatory Affairs Specialist – Prepares and submits documents to government health agencies to obtain trial approval.

How this role differs in a CRO vs. a Sponsor?

• In a CRO, the Regulatory Affairs Specialist handles submissions for multiple sponsors and multiple trials.

• In a sponsor company, this role concentrates solely on trials related to the company's own drugs.

Example: If a company wants to test a new vaccine, the specialist sends all necessary forms to the FDA or EMA to get study approval.

Feasibility and/or Start-Up Specialist – Works on the first steps of a study, like identifying potential sites and PIs for a specific study indication, setting up contracts with hospitals, assessing site suitability, and managing documentation. In some companies, the feasibility department operates independently, focusing on trial bidding, proposal preparation, site identification, and maintaining the company's database of investigator and hospital contacts.

Example: Before a hospital joins a cancer drug trial, the Start-Up Specialist makes sure the hospital has the right equipment, documentation and trained staff.

Data Management & Biostatistics – "The Number Checkers"

This team collects and analyzes all the information from the trial to evaluate treatment efficacy and safety.

Key Jobs in Data Management & Biostatistics:

Clinical Data Manager – Ensures that all patient information is collected, stored, and cleaned properly before final analysis.

Example: If 1,000 patients are in a study, the data manager verifies that all their test results are correctly entered into the system without errors.

How this role is different in a CRO vs. a Sponsor:

• In a CRO, Data Managers work with multiple trials from different companies.

• In a sponsor company, they focus on the sponsor's own products and trials.

SAS Programmer – Uses specialized software to analyze the trial results and find patterns.

Example: If doctors want to know if a new painkiller works faster than an old one, the SAS Programmer compares all patient pain scores to determine differences.

Safety & Pharmacovigilance – "The Drug Watchdogs"

This team checks for side effects and safety issues during the trial and after market release.

Key Jobs in Safety & Pharmacovigilance:

Safety Associate – Collects side effect reports from doctors and patients, then sends them to health authorities.

Example: If patients in a new asthma drug trial experience dizziness, the Safety Associate records all cases and alerts the medical team.

Pharmacovigilance Scientist – Analyzes safety data to find trends in side effects and determines if additional safety measures are needed.

Example: If many patients taking a new antidepressant report headaches, the scientist investigates if the drug is the cause and recommends a warning label.

How this role is different in a CRO vs. a Sponsor:

• In a CRO, Safety Associates handle side effect reports for multiple studies.

• In a sponsor company, they focus only on the company's drugs.

Quality Assurance & Compliance – "The Rule Enforcers"

Or as I like to call them, the long arm of the law (ICH-GCP).

This team ensures trials follow Good Clinical Practice (GCP) guidelines and are inspection-ready.

Key Jobs in Quality Assurance & Compliance:

GCP Auditor – Visits hospitals and clinics to audit trial records and ensure all rules are being followed.

Example: If a doctor is missing important patient signatures in their study files, the auditor flags this as a serious issue.

Inspection Readiness Manager – Prepares CROs and sponsors for government inspections before drug approval.

Example: If the FDA is coming to check trial records, this manager reviews all documents to make sure they are correct and complete.

Other Important Roles in Clinical Research (in both Sponsor & CRO companies)

Business Development & Market Access – Identifies new opportunities and ensures medicines reach patients effectively.

Legal & Ethics Teams – Handle contracts, safeguard patient rights, and obtain trial approvals.

Medical Writers – Create clear, accurate reports, study summaries, and regulatory documents.

Vendor Managers – Coordinate with external partners like labs, software providers, and service companies.

Site Relationship Managers – Support hospitals and clinics to maintain study engagement and resolve challenges.

Before we dive into clinical trial site roles, I want to note that there are many different companies, structures, and organizations—from big players to small "underdogs"—which significantly determine the scope of each role above. Now, dear CRAs, let me tell you: there's no such thing as "this doesn't fit my job description." Yes, there are boundaries, depending on your company, but remember - you're in this amazing position where you connect with everyone: sites, CROs, and sponsors. You see their challenges, understand their goals, and help bridge the gaps. You're basically a trial diplomat! Need to help a PI figure out their payment status? You're on it. Site coordinator struggling with their EDC login? You've got their back. Company needs feasibility data for a new study bid? You'll make it happen. The RA team needs help with submissions - you pitch in. New CRAs need mentoring? You step up. Site negotiations need to be done — you'd better bring your A-game! Marketing team needs blog content? ... well, you write articles 😉! Just kidding. But you get my point - being a CRA means being adaptable, solution-focused, and ready to help wherever needed. It's what makes this role both challenging and incredibly rewarding.

As I mentioned earlier, there are some nuances to this - some companies prefer to keep you more specialized in just one or few things, while other companies don't mind being more broad and giving you the space to do your thing in every aspect possible.

Jobs at a Clinical Trial Site

Clinical trial sites are hospitals, research centers, or private clinics where patients receive investigational treatments as part of a clinical study. Unlike CROs or sponsor companies, these professionals work directly with patients to ensure the study runs smoothly and that participants are safe.

If a clinical trial were a movie production, the sponsor company would be the studio financing the film, the CRO would be the film crew organizing everything, and the clinical trial site would be the actors, directors, and production team making it happen on screen.

Investigator & Research Team

Investigator (PI or SI) – This is essentially the doctor conducting the clinical trial, either as the Principal Investigator (PI) or Sub-Investigator (SI). If you have a medical background and enjoy working with patients while helping advance science, this role is perfect for you. I have friends who are doctors who (very sadly) believe they need to become a CRA or take another role is either CRO or sponsor company in order to make money. Unfortunately, young doctors aren't well paid (at leats in Bulgaria) for their hard work and long hours. I always advise them to join an investigator team instead, as this will open their career path in clinical trials. Once they gain enough experience they could become PIs, and then they'll make considerably more than a CRA! 😉

How this role is different from working as a regular doctor?

Instead of only treating patients with approved medicines, investigators test new treatments that could become future standard therapies.

Being a PI or SI allows doctors to be involved in cutting-edge medicine while still treating patients.

Once a doctor gains enough experience as an investigator, they can become highly sought-after in the research field and earn significantly more than some industry roles.

Example: A hospital is running a study for a new diabetes treatment. The PI meets with patients, checks their health before they start the treatment, and monitors their progress throughout the study.

Clinical Trial Coordinator/ Study Coordinator (CTC/SC)

Manages the day-to-day activities of the study at the site.

Schedules patient visits, organizes paperwork, records the data captured during patient visits in the EDC, and ensures the trial follows correct procedures.

• Acts as the bridge between doctors, nurses, patients, and the sponsor/CRO.

How this role is different from a hospital administrator:

• A CTC focuses only on clinical research and supports the specific needs of a clinical trial, such as keeping track of study timelines, patient visits, and reporting requirements.

Example: If a clinical trial requires a patient to have blood tests every two weeks, the CTC ensures the appointments are scheduled and that results are entered into the trial database.

Other Key Roles at a Clinical Trial Site

Some positions don't fit into one category but are still critical to the success of the trial.

• Lab Technicians – Process patient blood samples and test results for the study.

• Pharmacists – Ensure investigational drugs are stored, prepared, and dispensed correctly.

• Data Entry Coordinators (unless the SC handles this task) – Input and verify patient data into clinical trial systems.

And now, Which Career Path is Right for You?

• Love science & labs? 👉 R&D or Biostatistics

• Enjoy organizing & planning, putting out fires? 👉 Clinical Operations

• Interested in laws & regulations? 👉 Regulatory Affairs

• Want to communicate science? 👉 Medical Writing or Medical Affairs

• Care about safety & ethics? 👉 Pharmacovigilance or Quality Assurance

Clinical research offers many career paths, and you can fairly easily move between departments based on your interests!

There are opportunities for career growth and movement between these sectors, depending on your interests and skills. Whatever you choose, the most important thing is simply to start somewhere.

Good luck! ✌️

🎄 On the first day of Christmas, my sponsor gave to me… 🎄

A Protocol in a Pear Tree

Because every CRA knows, without that protocol, we’re just wandering aimlessly through site visits like lost elves.

🎄 On the second day of Christmas, my sponsor gave to me… 🎄

Two Monitoring Visits

Back-to-back, of course, because why not? Santa’s sleigh may run on reindeer, but CRAs run on adrenaline and caffein.

🎄 On the third day of Christmas, my Data Manager gave to me… 🎄

Three Queries Pending

Oh, the joy of chasing those elusive query resolutions. They’re like naughty kids on the “nice” list – always slipping through the cracks.

🎄 On the fourth day of Christmas, my sponsor gave to me… 🎄

Four Crazy Deadlines

Nothing screams “Merry Christmas” like juggling IMV reports, site activation timelines, and a sprinkle of EDC updates.

🎄 On the fifth day of Christmas, my sponsor gave to me… 🎄

FIVE SDV (back)LOGS!

Gold rings? No, we prefer source data verification logs that don’t make us cry. It’s a festive miracle when they’re complete!

🎄 On the sixth day of Christmas, my PI gave to me… 🎄

Six PI Signatures

Gathering PI signatures is like hunting for snow in July – challenging but not impossible (with the right snacks maybe).

🎄 On the seventh day of Christmas, my sponsor gave to me… 🎄

Seven Sites Recruiting!

Recruitment goals twinkle like Christmas lights – bright, beautiful, and ever so hopeful. May the patients flock like reindeer to a sleigh!

🎄 On the eight day of Christmas, my site gave to me… 🎄

Eight Missing CRFs

Nothing brings a festive frown faster than realizing the CRFs were “misplaced.” Let’s all sing carols until they’re found.

🎄 On the ninth day of Christmas, my site gave to me… 🎄

Nine Queries Answered

Sweet satisfaction! Closing queries feels like unwrapping presents early. Silent night, holy site…

🎄 On the tenth day of Christmas, my sponsor gave to me… 🎄

Ten Pages Report

Your monitoring report is shaping up! By now, it’s as detailed as grandma’s Christmas fruitcake recipe.

🎄 On the eleventh day of Christmas, my sponsor gave to me… 🎄

Eleven Protocol Amendments

What’s a clinical trial without a few amendments? Just think of them as gifts that keep on giving (and re-training)!

🎄 On the twelfth day of Christmas, my Project Manager gave to me… 🎄

Twelve Emails Waiting

No CRA inbox is complete without a dozen “URGENT” emails from sites, sponsors, and Santa himself. Don’t worry – you’ve got this, elf!

HO-HO-HO and Merry Christmas!

May your emails be merry, your queries be bright,

And may all your deadlines not keep you up at night.

Cheers to a festive season full of joy, laughter, and maybe even a little time off. Ho ho ho! 🎄🎁

AI in Diagnostics: Pioneering New Frontiers

The integration of AI into diagnostics is transforming one of the most critical steps in clinical trials—the identification of eligible patients. Accurate and timely diagnosis is essential for enrolling patients who meet the specific inclusion and exclusion criteria. However, traditional diagnostic methods often struggle to keep up with the growing complexity of clinical trials, especially in precision medicine. Manual methods of reviewing patient histories, analyzing test results, and matching individuals to trials are time-consuming and prone to human error.

AI is revolutionizing this space by automating the diagnostic process, offering unparalleled accuracy, speed, and scalability. AI-driven diagnostic tools, powered by machine learning algorithms, can analyze vast amounts of data from medical records, imaging results, and genomic profiles, identifying subtle patterns that human practitioners might miss. These tools can predict the likelihood of specific conditions, detect early signs of diseases like cancer, and assess patient eligibility for clinical trials based on complex, multi-layered criteria.

For example, AI-powered diagnostic systems can analyze MRI or CT scans to detect early-stage tumors that might be invisible to the human eye, or assess genetic markers that signal a predisposition to certain diseases. The result is faster, more reliable diagnoses, which not only improve patient outcomes but also expedite the clinical trial recruitment process. This is especially crucial for trials requiring participants with rare genetic mutations or specific biomarkers that can be difficult to identify using traditional methods.

AI in diagnostics has also expanded its reach into telemedicine and remote monitoring, allowing real-time patient data to be continuously assessed, no matter the location. In decentralized clinical trials, AI plays an instrumental role in monitoring patient health remotely, ensuring that patients are accurately diagnosed, and their eligibility for trials is continually re-evaluated as their health evolves.

The Rise of Bulgarian Med-Tech Startups

Bulgaria is emerging as a vibrant hub for med-tech innovation, with a growing ecosystem of startups focusing on health technology, biotechnology, and AI-driven medical solutions. The country’s strategic location in Europe, combined with its highly skilled workforce and competitive business environment, has made it an attractive destination for tech entrepreneurs and investors. Bulgaria’s tech ecosystem benefits from strong academic foundations, particularly in mathematics, computer science, and engineering, which fuel the development of advanced technologies in the healthcare space.

In recent years, several Bulgarian med-tech startups have garnered international attention for their cutting-edge solutions aimed at addressing global healthcare challenges. These companies are leveraging AI, machine learning, and big data analytics to improve diagnostic accuracy, streamline healthcare delivery, and enhance patient care. Many of these startups have formed partnerships with international research institutions, pharmaceutical companies, and hospitals, driving innovation in the clinical research landscape.

Kelvin Health: AI-Driven Diagnostics in Action

One standout example from Bulgaria’s med-tech scene is Kelvin Health, a startup that is making waves with its AI-powered diagnostic solutions. Founded in Sofia, Kelvin Health focuses on non-invasive medical diagnostics using thermal imaging technology, combined with advanced AI algorithms. The company's flagship product is a mobile-based solution that uses thermal cameras to detect early signs of chronic diseases, particularly cancer.

Kelvin Health’s approach is centered around using AI to analyze thermal images of the human body, identifying subtle temperature variations that could indicate abnormalities, such as inflammation, infection, or malignancy. This technology provides a cost-effective, non-invasive alternative to traditional diagnostic methods like biopsies or X-rays, which are often more invasive, expensive, and less accessible in remote areas.

The company’s AI-driven platform is designed to quickly and accurately detect early signs of diseases like breast cancer, where temperature anomalies in breast tissue can signal tumor development long before physical symptoms manifest. This makes it an ideal tool for screening large populations, particularly in resource-limited settings, where access to advanced diagnostic tools may be restricted.

Kelvin Health’s technology has significant potential for clinical trials as well. By providing a fast and non-invasive method for identifying potential participants based on early-stage disease detection, the company can help accelerate the recruitment process. For trials targeting specific cancers or chronic conditions, Kelvin Health’s thermal imaging technology could play a key role in ensuring that the right patients are enrolled early, improving trial outcomes and reducing dropout rates.

Furthermore, Kelvin Health’s platform is highly portable and user-friendly, making it well-suited for decentralized trials, where patients may not have easy access to traditional diagnostic centers. By using AI to analyze thermal images remotely, the platform allows clinical researchers to monitor patients in real-time, ensuring that they remain eligible for trials throughout the study period.

AI for Patient Selection: A Game Changer for Clinical Trials

Patient recruitment is one of the most challenging and time-consuming steps in clinical trials. In many cases, clinical trials are delayed or even fail because it is difficult to find patients who meet the specific inclusion and exclusion criteria. Traditional methods rely on doctors and medical staff manually screening patient records, a process that is both labor-intensive and prone to human error. Furthermore, the complexity of many modern trials—with their highly specific criteria that often span multiple factors such as age, genetics, disease progression, and comorbidities—makes manual screening a nearly impossible task for clinicians.

Recently, I had a discussion with a colleague—the CEO of the first founded SMO in Bulgaria, Mr. Hristiyan Kosturski—during one of the regular Clinical Research Bulgaria meetups. One of the questions we discussed was exactly how SMOs are currently contributing to patient enrollment in clinical trials. It's a very simple yet backbreaking process. The study coordinators (usually during their lunch break) gather as many patient dossiers as they can carry and then spend the next hour or so going page by page, searching for patients who might be eligible for at least one of the 20 trials currently being run at this clinical research center. As opportunistic and proactive as this might be, I thought it would be highly inefficient. No one could remember and know by heart the criteria for 20+ trials.

This is where AI and machine learning models have emerged as game changers. AI can automate the process of patient selection by scanning thousands of patient records in real time and identifying individuals who are most suitable for a particular trial. For instance, an oncology trial may require patients with a specific genetic mutation, a particular stage of cancer, and an absence of certain comorbidities. AI can quickly sift through the electronic health records (EHR) of hundreds of patients and pinpoint those who match the trial criteria, a task that would take a team of doctors weeks or even months to accomplish manually.

Incorporating AI into this process offers several key advantages:

·       Speed and Efficiency: AI can perform in minutes what would take humans weeks. By rapidly scanning patient databases, AI models can identify candidates who meet specific trial criteria much faster than manual screening.

·       Accuracy and Precision: AI models can consider all aspects of the trial criteria simultaneously, including complex genetic markers or treatment histories. Doctors, on the other hand, are limited by their own experience and memory. AI ensures that no suitable candidate is overlooked.

·       Handling Complex Datasets: The inclusion and exclusion criteria for clinical trials are growing increasingly complex as we move towards precision medicine. Trials today often require patients to meet specific molecular or genetic profiles, making it nearly impossible for a human to remember and apply every criterion consistently. AI can handle this complexity with ease, ensuring that patient selection is both accurate and comprehensive.

For example, a CRO conducting a Phase II clinical trial in oncology might need to recruit patients with a specific gene mutation, previous chemotherapy exposure, and no history of cardiac disease. Rather than relying on site staff to manually review patient charts, AI can automatically flag the right candidates by cross-referencing genetic test results, treatment records, and patient histories in EHRs.

Moreover, AI can be programmed to continuously update as new patient data becomes available, meaning it can monitor patient records in real-time and flag any new eligible participants. This level of automation ensures that recruitment is not only faster but also remains an ongoing process, identifying suitable patients even after the trial has started.

AI’s Role in Personalized Medicine

The application of AI in patient selection also extends to personalized medicine, where treatments are tailored to individual genetic or molecular profiles. In many cases, the challenge is not only finding patients for trials but also matching them with the most effective treatment based on their specific biology. AI excels in this regard by integrating genomic data, biomarker analysis, and patient histories to match individuals with the right clinical trials. This not only improves the chances of patient success but also accelerates the development of more personalized therapies.

A promising area in personalized medicine is the use of AI algorithms to predict patient outcomes based on trial data. By analyzing the success rates of different treatments for patients with similar genetic or molecular profiles, AI can provide predictive insights that guide trial designs and patient matching. This capability holds immense potential for both increasing trial efficacy and improving patient outcomes.

AI Beyond Patient Selection: Predictive Analytics

In addition to patient selection, AI can forecast patient retention and predict the likelihood of a participant adhering to the trial protocol. This predictive capability is especially crucial in trials that require long-term patient commitment, such as those for chronic diseases. AI algorithms can evaluate past behavior, health records, and socio-economic factors to identify patients who are more likely to complete the trial, thus reducing dropout rates and ensuring that trials are completed on schedule.

AI also facilitates remote patient monitoring, allowing researchers to track participants in real-time and intervene when necessary. For instance, if a patient is scheduled for a follow-up visit but misses their appointment, AI could automatically trigger a reminder and even schedule a telemedicine consultation. This proactive management significantly improves patient retention and adherence to trial protocols.

AI-Powered Virtual Clinical Research Associates: The Future of Trial Management

The role of a clinical research associate (CRA) is pivotal to the success of a clinical trial. CRAs are responsible for monitoring trial sites, ensuring that protocols are followed, data is collected correctly, and patient safety is maintained. However, this role is also extremely demanding, requiring CRAs to balance multiple responsibilities, travel to various trial sites, and provide ongoing support to site staff. With the rise of decentralized trials and the increasing complexity of protocols, the need for more efficient trial management has never been greater.

AI-powered virtual clinical research associates (vCRAs) present a solution to these challenges. A vCRA is an AI-driven system that can assist in managing trial protocols, answering questions from site staff, and providing real-time monitoring. Imagine a system that has complete knowledge of the trial protocol and can respond instantly to any inquiry from the site team, whether it's about patient eligibility, dosing schedules, or reporting timelines. Unlike human CRAs, these virtual assistants are available 24/7, providing constant support and ensuring that the trial runs smoothly.

Key Benefits of AI-Powered vCRAs

·       Protocol Mastery: A vCRA knows the trial protocol inside out. It can provide immediate, accurate answers to site staff, reducing the need for back-and-forth communication and lengthy searches through trial documentation. For instance, if a site coordinator needs clarification on a dosage adjustment, the vCRA can provide the answer instantly, without the need for contacting a CRA or waiting for a response.

·       24/7 Availability: Human CRAs have limited working hours and can only monitor a finite number of sites. vCRAs, however, can work around the clock and simultaneously support multiple sites across different time zones. This capability is especially useful for global trials where real-time assistance is crucial for maintaining consistency across sites.

·       Reducing Administrative Burden: Traditional CRAs spend a significant amount of time on administrative tasks such as data entry, query resolution, and scheduling site visits. AI-powered vCRAs can automate many of these tasks, allowing human CRAs to focus on more strategic aspects of trial management, such as patient safety monitoring and risk mitigation.

·       Enhanced Communication: In trials with multiple sites and stakeholders, communication can often become fragmented. vCRAs streamline communication by acting as a central hub for information. They ensure that all stakeholders—from site coordinators to sponsors—are updated in real time, reducing the likelihood of miscommunication and protocol deviations.

Monitoring and Compliance

AI-powered vCRAs can also be programmed to monitor trial compliance in real-time. For example, they can flag deviations from the protocol and generate alerts for human CRAs to investigate. This level of oversight is invaluable in ensuring that the trial adheres to regulatory standards, minimizing the risk of non-compliance and the costly delays associated with regulatory audits.

Furthermore, AI-driven systems can automate the generation of regulatory reports, ensuring that documentation is accurate, complete, and submitted on time. This automation reduces the administrative workload for CRAs and site staff, freeing up valuable time for more critical activities such as patient monitoring and safety assessments.

Future Potential of AI-Powered vCRAs

As AI technology continues to advance, we can expect vCRAs to become even more sophisticated. Future iterations could include natural language processing (NLP) capabilities, allowing vCRAs to engage in more complex conversations with site staff, answer nuanced questions, and even provide training for new team members. These systems could also integrate with other AI tools, such as predictive analytics models, to proactively address potential issues before they arise. For example, if a vCRA detects that patient enrollment is lagging at a particular site, it could suggest targeted recruitment strategies or flag the issue for further investigation.

The Benefits of AI for Stakeholders in Clinical Trials

The implementation of AI technologies brings significant benefits to all stakeholders involved in clinical trials, including medical centers, site management organizations (SMOs), contract research organizations (CROs), and sponsors. Each of these entities plays a critical role in the clinical trial process, and AI can help them improve efficiency, reduce costs, and achieve better trial outcomes.

For Medical Centers

Medical centers involved in clinical trials often face resource constraints, especially in terms of staff availability and patient recruitment. AI can alleviate these pressures by automating many time-consuming tasks, such as patient selection and data analysis. This allows clinical staff to focus on more value-added activities, such as patient care and safety monitoring. AI can also enhance the quality of care by ensuring that patients are matched to the most appropriate trials based on their unique health profiles.

Additionally, medical centers benefit from AI’s ability to monitor patients in real-time. Remote monitoring tools powered by AI can collect data on patient adherence, side effects, and overall health, allowing doctors to intervene more quickly if issues arise. This improves patient outcomes and helps maintain the integrity of the trial data.

For Site Management Organizations (SMOs)

SMOs manage clinical trial sites and are responsible for ensuring that trials are conducted according to the protocol. AI can streamline site management by automating key processes, such as patient enrollment, data collection, and protocol adherence monitoring. AI-powered systems can also track the performance of individual sites in real time, flagging any issues that need to be addressed before they become significant problems.

By using AI to optimize resource allocation, SMOs can manage multiple sites more efficiently, reducing the need for frequent site visits and improving the overall speed of trial execution. AI also enhances communication between sites and sponsors, ensuring that information is shared promptly and accurately.

For CROs and Sponsors

For CROs and sponsors, the benefits of AI are even more pronounced. AI allows CROs to manage multiple trials simultaneously, reducing the time and resources needed for data management, patient recruitment, and protocol compliance. AI-powered systems can generate real-time reports on trial progress, allowing sponsors to make informed decisions about trial continuation or modification.

Sponsors also benefit from the cost savings associated with AI. By automating many labor-intensive tasks, AI reduces the need for human resources, leading to lower operational costs. Furthermore, the speed and accuracy of AI-driven patient recruitment and data analysis can significantly shorten trial timelines, allowing new therapies to reach the market faster.

Overcoming Challenges: Ethical Considerations and Data Security

While Artificial Intelligence (AI) is undoubtedly transforming clinical trials by streamlining processes, enhancing accuracy, and reducing human error, its rapid development also raises important ethical and regulatory challenges. Ensuring patient safety, maintaining data privacy, and addressing ethical concerns are critical to the successful deployment of AI in healthcare and clinical research. However, the current regulatory environment, particularly in Europe, presents significant hurdles to AI innovation. Without adapting these frameworks, we risk stifling the very progress that could revolutionize healthcare.

AI Regulation in Europe: A Double-Edged Sword

Europe has long been a leader in data protection and privacy, with regulations like the General Data Protection Regulation (GDPR) setting the global standard for how personal data, including sensitive health data, should be managed. While this emphasis on privacy is critical for ensuring that patient data is handled responsibly, the stringent regulations can sometimes hamper the development and implementation of AI technologies, especially in the context of clinical trials.

The European Union (EU) is also at the forefront of AI regulation with its Artificial Intelligence Act, a proposed legal framework aimed at managing AI’s risks while encouraging innovation. However, this legislation, like GDPR, places a strong emphasis on risk management and ethics, sometimes at the expense of innovation. AI systems, particularly those used in healthcare, are classified as “high-risk,” meaning they must comply with strict requirements regarding data processing, transparency, and accountability.

These regulations, while well-intentioned, can slow down the deployment of AI in healthcare by creating bureaucratic obstacles. For instance, clinical trials involving AI technologies must undergo rigorous scrutiny to ensure that patient data is anonymized, that AI decisions are explainable, and that the algorithms are free from bias. While these safeguards are essential for protecting patient rights, the process of proving compliance can be time-consuming, costly, and overly restrictive.

Moreover, the requirement for AI systems to be “transparent” in their decision-making often clashes with the nature of advanced machine learning models, such as deep learning algorithms, which are inherently complex and not easily interpretable by humans. This disconnect between regulatory expectations and the technical realities of AI development creates friction and often delays the implementation of cutting-edge AI tools in clinical settings.

How Over-Regulation Can Stifle Innovation

One of the most significant challenges posed by AI regulation in Europe is the risk of over-regulation, where the sheer volume and complexity of compliance requirements create barriers to innovation. Med-tech startups, in particular, face enormous hurdles when trying to bring new AI-driven technologies to market. Smaller companies often lack the resources to navigate the complex regulatory landscape, leading to delays in product development and even the abandonment of promising technologies.

For example, under the EU’s Artificial Intelligence Act, high-risk AI systems must adhere to strict guidelines on transparency, accountability, and bias mitigation. These requirements are crucial for ensuring that AI tools are safe and effective, but they also place a heavy burden on companies to explain how their algorithms work and prove that their models are free from discriminatory biases. Meeting these requirements can be incredibly challenging, especially for smaller firms with limited access to technical and legal expertise.

This regulatory burden can slow down the pace of AI innovation in Europe, putting the region at a competitive disadvantage compared to countries with more flexible regulatory frameworks, such as the United States and China. In those regions, AI startups face fewer regulatory roadblocks, allowing them to bring new technologies to market more quickly and iterate on their products in real time.

A growing concern in Europe is the regulatory lag—the time it takes for regulations to catch up with technological advancements. AI is evolving rapidly, but the regulatory frameworks governing its use in clinical trials are often outdated or insufficiently tailored to the unique challenges posed by AI technologies. This lag prevents new AI tools from being deployed at scale, slowing down their potential impact on clinical trials and healthcare as a whole.

The Need for Regulatory Evolution: Balancing Risk and Innovation

To foster AI-driven innovation in clinical trials, it is essential that regulatory frameworks in Europe evolve to strike a better balance between managing risks and promoting progress. Current regulations are heavily focused on mitigating potential harms, which, while necessary, should not come at the expense of slowing down technological advancements that could dramatically improve healthcare outcomes.

Here are some key areas where regulatory evolution is needed:

·       Proportional Regulation Based on Context

AI systems used in healthcare and clinical trials should be regulated proportionally to the risks they pose. Not all AI applications present the same level of risk. For example, an AI tool that automates administrative tasks or assists in patient recruitment is lower risk compared to an AI system that directly influences medical decisions. Regulators should adopt a risk-based approach that allows lower-risk AI systems to be deployed more rapidly, while maintaining stricter oversight for high-risk applications like diagnostic AI or autonomous treatment recommendations.

·       Encouraging Innovation Sandboxes

One way to balance regulation and innovation is by establishing regulatory sandboxes—controlled environments where AI developers can test their technologies with temporary regulatory exemptions. Sandboxes allow innovators to experiment with new AI solutions in real-world clinical trials while ensuring patient safety under close supervision. Regulatory bodies can observe these trials and gather data on the AI system’s performance, helping them craft more informed and flexible regulations in the future.

·       Flexible Compliance Pathways

Current regulations often require companies to demonstrate compliance with rigid, one-size-fits-all standards, which may not be appropriate for all AI systems. Instead, regulators should offer more flexible compliance pathways, allowing companies to demonstrate safety and efficacy in different ways, depending on the nature of the AI technology and its application. For example, instead of requiring all AI systems to be fully transparent and interpretable, regulators could permit the use of “black box” models as long as their outcomes can be validated through rigorous testing and real-world performance data.

·       Faster Adaptation to Technological Advancements

Regulatory bodies need to adopt more agile approaches to updating AI guidelines. As AI technologies evolve, so too must the regulations governing their use. This means shortening the regulatory lag by establishing faster review processes for AI-driven innovations and ensuring that AI systems can be updated over time without having to undergo entirely new rounds of regulatory approval. The FDA’s recent move toward “adaptive” AI regulation in the U.S. is a step in this direction, allowing AI systems to evolve while remaining compliant.

·       Public-Private Partnerships for AI in Clinical Trials

To accelerate the safe integration of AI in clinical trials, regulators and AI developers should work more closely together. Public-private partnerships could foster innovation while maintaining ethical oversight. These collaborations could focus on co-developing guidelines, sharing best practices, and setting up cross-border regulatory frameworks that ensure harmonization and ease the burden on companies developing AI technologies for clinical use.

Why This Change Is Critical for Progress

If Europe wants to remain at the forefront of AI-driven healthcare innovation, regulatory bodies must rethink how they approach AI in clinical trials. Overly rigid and complex regulations can inhibit progress, delay life-saving innovations, and drive companies to develop their products elsewhere, where regulatory environments are more conducive to experimentation and iteration.

The healthcare industry, and clinical trials in particular, stand to benefit immensely from AI’s ability to optimize processes, reduce costs, and enhance patient outcomes. But for AI to realize its full potential, Europe must embrace regulatory frameworks that support responsible innovation. Striking the right balance between safeguarding patient rights and enabling technological advancement is critical to ensuring that Europe does not fall behind in the global AI race.

Ultimately, by adopting a more flexible and adaptive regulatory approach, Europe can foster a more dynamic med-tech ecosystem, one that not only protects patients but also encourages the rapid development of AI solutions that could revolutionize clinical trials and healthcare as a whole.

Why Do We Hold AI to Higher Standards?

One of the key questions that often arises is: why do we hold AI to such high standards compared to humans? AI has already proven that it can significantly reduce human error in tasks like patient selection, data monitoring, and protocol management. Yet, despite these advantages, AI is often subject to far more rigorous scrutiny. In many cases, AI systems are required to meet a higher bar for safety and transparency than their human counterparts, even though studies have consistently shown that human-driven processes introduce more variability and risk.

For instance, a doctor or clinical researcher manually reviewing patient records for a trial might miss a key eligibility criterion due to workload pressures or simple oversight. In contrast, AI systems can cross-check every criterion against thousands of records in seconds, without fatigue or bias. By automating these tasks, AI minimizes the risk of costly or dangerous mistakes that could delay a trial or compromise patient safety.

It’s important to ask why we place such stringent expectations on AI when, in reality, humans are much more prone to error. AI’s ability to continuously learn and improve means that its accuracy only increases over time. Meanwhile, human performance tends to degrade under stress, long hours, or cognitive overload—all common conditions in clinical trials.

Data Security and Privacy: Stronger with AI

One of the primary concerns about AI in clinical trials is how it handles large volumes of sensitive patient data. While data security is undoubtedly important, it’s essential to acknowledge that AI systems can actually improve data protection. With robust encryption methods, automated monitoring, and secure data transfer protocols, AI can offer stronger safeguards than manual systems.

AI also provides advanced capabilities for detecting and preventing data breaches. By analyzing patterns of data access and usage in real-time, AI can flag suspicious activity far more quickly than human security teams. This ability to proactively defend against cyber threats makes AI an invaluable tool for protecting patient data in clinical trials, where security is paramount.

Moreover, AI enables advanced anonymization techniques that protect patient identities while still allowing researchers to draw valuable insights from clinical trial data. By using techniques such as differential privacy, AI can ensure that data is used in ways that are compliant with regulations like the GDPR and HIPAA, without compromising the integrity of the research.

Current Data Protection Regulations: Enhancing with AI

Regulatory frameworks such as the General Data Protection Regulation (GDPR) and the Health Insurance Portability and Accountability Act (HIPAA) have been put in place to ensure patient privacy and data security. However, these regulations were designed before AI became a driving force in healthcare. While they provide a strong foundation, AI actually enhances compliance with these laws by introducing automated systems that reduce the potential for human error and ensure real-time monitoring of data use.

With AI, compliance becomes more efficient and reliable. For example, consent management—a vital component of clinical trial ethics—can be streamlined with AI-powered systems that ensure patients are fully informed about how their data will be used. These systems can track consent forms, remind researchers of data protection requirements, and flag any breaches of protocol, all with far greater accuracy than a human team could manage.

The Role of AI in Strengthening Regulatory Compliance

Regulatory bodies like the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) are already recognizing the benefits of AI in clinical trials. While these organizations are in the process of adapting their guidelines to accommodate AI technologies, it’s important to remember that AI can actually enhance compliance with existing regulations. For instance, AI can help monitor trial adherence in real-time, flagging deviations from protocols and automatically generating reports that ensure transparency and accountability.

One of the most exciting developments is how AI can help improve post-market surveillance for clinical trials. After a drug or treatment is approved, AI systems can continue to monitor patient outcomes and detect any unexpected adverse events far more quickly than traditional methods. By analyzing patterns across multiple trials and patient populations, AI can help regulators make more informed decisions, enhancing public safety.

FDA and EMA Moving Toward AI Integration

In recent years, both the FDA and EMA have begun to explore the integration of AI into their regulatory frameworks. For example, the FDA’s proposed regulatory framework for AI and machine learning-based software as a medical device (SaMD) recognizes that AI systems are dynamic, capable of learning and evolving. This is a crucial distinction, as traditional regulatory frameworks are designed around static products that do not change once they hit the market. AI, on the other hand, improves over time, and the FDA’s framework acknowledges the need for continuous monitoring and real-time updates.

The EMA’s Artificial Intelligence in Healthcare Working Group is similarly focused on developing guidelines for the ethical and safe use of AI in clinical trials and healthcare. The EMA recognizes that AI offers significant advantages, not only in terms of efficiency and accuracy but also in improving patient safety. By integrating AI into trial design and execution, the EMA aims to modernize clinical trials, making them more inclusive, patient-centric, and transparent.

Both the FDA and EMA are taking a proactive approach to AI, ensuring that these technologies are implemented in ways that maximize their benefits while minimizing risks. Importantly, these regulatory bodies are working to balance the need for innovation with the assurance of safety, without holding AI to impossibly high standards that would hinder its adoption.

AI Ensures Greater Transparency and Accountability

One of the often-overlooked benefits of AI is its ability to ensure greater transparency in clinical trials. AI systems can automatically log every action taken during a trial, from patient recruitment to data collection and analysis. This level of record-keeping provides an audit trail that is far more detailed and accurate than manual documentation, ensuring that all stakeholders have access to the same data and can verify the integrity of the trial.

By generating real-time reports and ensuring that all data is accurately recorded and securely stored, AI enhances the transparency of the entire trial process. This transparency not only satisfies regulatory requirements but also builds trust with patients, sponsors, and investigators, reinforcing the ethical integrity of the trial.

The Ethical Benefits of AI: Fairness and Equality…

*This article is part of Pharma Focus Europe Magazine 's issue 5. If you'd like to read the full article, check out the e-book.

Also, don’t forget to subscribe for The CRA Wizard’ newsletter and checkout the blog here ✌️

Step 1: Find a Trial — Welcome to Bulgaria

Let’s start with the basics: why even conduct a clinical trial in Bulgaria? Well, the answer is simple — Bulgaria is actually a hidden gem in the world of clinical research. As a part of the post-socialist bloc, Bulgaria is surprisingly well-developed, especially in terms of education and healthcare. You’ll find that both men and women are well-educated (usually with a university degree) and hard-working. Doctors and healthcare professionals are still regarded as pillars of the community, even though their salaries are not exactly on par with those in Central or Western Europe.

Another massive bonus is Bulgaria’s patient population. It’s ideal for trials on heart disease, oncology, respiratory conditions, diabetes, obesity, and gastroenterology, as the number of patients suffering form these disease is significantly higher in comparison to other countries while at the same time - the patients could actually benefit form those trials! Conducting trials here not only benefits the sponsors but also the patients, offering access to cutting-edge treatments that might otherwise take years to arrive and not be wildly accessible to everyone.

Step 2: The Art of finding Doctors — Where Rakia and Research Collide

Now, on to the crucial part: finding the right doctors. If you’ve spent even a day in Bulgaria, you’ll know that the most reliable way to find anything is through “BG Mama” (yes, even your clinical trial). Other viable options include stalking the medical professionals on SuperDoc, Instagram, or Facebook. Networking events, business cocktails, conferences, and seminars are excellent opportunities to connect with doctors. One minute, you're discussing the latest advancements in clinical research over a glass of wine, and the next, you're exchanging contact information with a potential principal investigator for your study (this is what I call a fruitfull feasibility 😉). These professional gatherings often lead to valuable connections and collaborations in the Bulgarian clinical research community. The bond formed over a shared bottle of rakia is unbreakable — sort of like the clinical trials version of the "rakiavengers."

Step 3: Navigating Submissions with the Bulgarian Drug Agency (BDA)

If you think you've experienced bureaucracy before, prepare yourself for the unique experience of dealing with the Bulgarian Drug Agency (BDA). Submissions here, as it is usually dealing with state institutions, require a special approach. While perfectly organized folders and extensive paperwork are important, what's crucial is your attitude and preparation.

When visiting the BDA, remember these key points:

• Always approach with a positive and respectful demeanour. You have to pay your respect 😅

• Listen carefully to the staff's instructions and write down everything

• Try to schedule an appointment in advance - while this is an unofficial rule, this helps ensure they're expecting you and can allocate time, given their typically heavy workload

• Be patient and understanding - the process may take time, but maintaining a cooperative attitude goes a long way

Remember, the staff at the front desk, often referred to as "lelka" (auntie), are experienced professionals dealing with a high volume of submissions. Treat them with respect, follow their guidance, and you'll navigate the process much more smoothly.

I recently had a great personal experience that completely changed my perspective on dealing with administration work. When I started handling non-interventional studies - a type of trial I had never worked on before - I found myself lost in all the requirements for the submission documentation. Instead of struggling alone, I decided to call the BDA directly and ask. To my surprise, the woman who answered was incredibly helpful and well-prepared. She immediately started citing all the relevant regulations, where to find them, and how to prepare my submission. This experience taught me that sometimes, reaching out for help can save you a lot of time and stress. The BDA staff are often more than willing to guide you through the process, especially when you're dealing with unfamiliar territory.

Step 4: Negotiation — The Bulgarian Tax of Doing Everything

Welcome to Bulgaria, where negotiations aren’t just encouraged, they are necessary. Whether you're negotiating site budgets, contracts, or even where to grab lunch, you’ll have to flex those bargaining muscles - this is just a huge part of our culture, it would be considered rude if you don’t. Everything here involves an extra tax: the “doing everything you can’t even think of” tax. What does that mean? Well, it means get ready to explain everything five times, then re-explain it, and then explain it again — just for good measure.

Now, let's take a more serious look at the negotiation process. Different clinical sites have different Standard Operating Procedures (SOPs) and varying fee structures for their services. There's no one-size-fits-all solution, and as a CRA, you'll need to learn to be flexible while also knowing when to draw the line for yourself or the sponsor.

Site fees can vary wildly and may include:

• Start-up fees

• Pharmacy fees

• IMP dispensation fees

• Pharmacist fees

• Administration fees

• Annual agreement administration and implementation fees (my personal favorite!)

The bottom line is that you need to adapt and execute reasonable requests. Put yourself in the hospital's shoes. After all, you share a common goal: to get the study off the ground and bring new treatments to the patients who need them most. Remember, flexibility and understanding go a long way in successful negotiations.

Step 5: The Pre-Study Visit (PSV) and site selection — Expectations vs. Reality

Let’s set the scene: you are on your Pre-Study Visit (PSV). You've been told that this particular clinical site is perfect—an outstanding study team with enough experience to rival a NASA control room. They’ve promised to recruit at least 50+ patients and enter all data into the EDC within timelines and basically give you zero stress for the duration of the study. Sounds like a dream, right?

Fast forward to reality: you arrive at the site on your first RMV (routine monitoring visit):

The study team seems to have forgotten half of what you discussed during the site initiation, and the recruitment at this point is... well, let’s just say a little optimistic…and somehow, the air conditioning in the monitoring room is both broken (in July) and making a loud noise at the same time. But hey, it’s fine... right?

Take a deep breath, my fellow CRA, and repeat after me: “I can fix this!”

The first RMV can be challenging, and that’s perfectly normal. At this stage, both the study team and yourself are still getting familiar with how the protocol works in practice. Deviations are more likely to pop up at this point — like little gremlins you didn't see coming. So, what’s the key? Pay extra attention, take your time, and re-train if you must. It's not a failure to go over things again; it's an investment in the site's future success.

If you take the extra effort now — correcting issues, addressing questions, and reinforcing protocol expectations — you’ll save yourself (and the site) a mountain of work down the road. So, instead of panicking, set your site up for success. Be the calming presence in the chaos and guide your team through the early bumps.

Trust me, after this first RMV, it’ll be smooth(er) sailing—until the next fire, at least!

The Ultimate Secret to Clinical Trials in Bulgaria: Connections, Connections, Connections

If you take one thing away from this guide, let it be this: connections are everything. In Bulgaria, knowing the right people and getting to know the people who matter in the clinical research industry can be the difference between a seamless study and one that ends in chaos. That’s why I founded the Clinical Research Bulgaria community. I wanted to create a space where CRAs, doctors, and anyone interested in the field could connect, network, and share their stories. From organizing events to inviting guest lecturers, we’re building something special here. After all, it's not just about research—it's about the people who make it happen. And I am a huge believer in the personal approach and human connection.

*If you are interested to join, or you would like to follow our group and all networking events, we are on LinkedIn: Clinical Research Bulgaria.

You never really know where your next great opportunity may come from, so it's crucial to network like an Olympic champion and always keep your options open.

I personally had a couple of great opportunities myself, precisely because of my network:

➡️ I was invited to write an article for the Pharma Focus Asia magazine, which landed on the cover! (here is the link to the article, part of it is also available in my blog) I am currently working on my next piece for Pharma Focus Europe.

➡️ I connected with my long-time career mentor and role model, Dan Sfera, who I'm sure has helped many CRAs on their way to success. I had the chance to meet him and talk — we even recorded a podcast together (here is the link, if you are interested, we do talk about what is like to be an eastern European CRA)

➡️ Finally, it's my personal belief that I landed my new role with Cromos because of my following— the algorithm worked brilliantly in my favour and connected me with liked minded people, who are now my teammates.

Stay connected people! ✌️

A Little About Me and My Wild Ride with Cromos Pharma

In case you were wondering, I’m currently the sole representative for Cromos Pharma in Bulgaria 🇧🇬 (for now). That’s right, I have been flying the Cromos flag solo. The past three months since I joined the company have been a whirlwind, to say the least, but nevertheless amazing! While it's a tremendous privilege to represent Cromos in Bulgaria, it also comes with significant responsibility. As the sole face of the company here, I'm committed to showcasing our best qualities and capabilities at all times. It's been an awesome experience to be part of such a forward-thinking organization. Cromos's proactive approach and innovative mindset provide me with ample opportunities to excel in my role. What's particularly gratifying is the balance they strike – I have the freedom to tailor our operations to the unique Bulgarian landscape while still benefiting from the support and resources of an internatinal company. This blend of autonomy and backing allows me to leverage my local expertise effectively, ensuring we make a meaningful impact in the Bulgarian clinical research scene. And by the way, we do have an awesome podcast!

I did have to convince quite a few people though, that we’re a legit company, despite not having a fancy office in Sofia. It turns out, working remotely is still a pretty strange concept in Bulgaria (shocking, I know).

Another huge personal milestone for me in the past few months — I got married! 👰🏼‍♀️ Married life has been an amazing experience, full of love and laughter. But along with the joy of tying the knot, I quickly realized that getting my name changed was going to be a bit more complicated than just updating my Instagram handle.

In addition to updating your name on personal documents like your address, passport, ID, and driving license, you'll also need to revise a few work-related documents.

You see, being the sole representative for several sponsors in Bulgaria meant I had to get all of my authorization documentation signed again. Every single piece, which, by the way, I had just obtained a few weeks prior, when I joined the company. So, while I was basking in newlywed bliss, I also had to explain to the project managers for each of my studies why the same person (me) suddenly had a different last name.

PS: And I am still waiting for my new driving license to be issued.

Final Thoughts

Clinical trials in Bulgaria are a unique blend of chaos, charm, and opportunity. Whether you're figuring out your communication strategy with the BDA, making lifelong friends over rakia, or building a network of healthcare professionals, one thing is clear: it’s never boring. And if you're a CRA looking to make your mark, Bulgaria is the place to be.

Dan Sfera: How CRA 2 In Eastern Europe Became A Clinical Research Associate and How You Can Too!

🎙️I recently had the honour of joining the legendary Dan Sfera 🤩 on his podcast! Meeting Dan, my clinical trials guru, was a surreal experience! Having followed his work for years, being a part of his podcast felt like meeting a mentor and a star all at once. Thank you, Dan, for this incredible opportunity! 🙏

In this article, we will explore various innovative trial designs, real-world applications, and their impact on patient recruitment. While these innovations offer benefits like accelerated drug development and improved patient- centricity, they come with challenges, including regulatory complexity and data security. Additionally, platforms like FindMeCure are bridging the gap between patients and researchers, enhancing access and diversifying the participant pool.

Clinical research has always been at the forefront of medical advancements, but the methods for conducting trials have undergone significant transformations in recent years. Innovative trial designs have emerged as a powerful force, revolutionising the way we approach clinical studies. These modern approaches not only expedite the drug development process but also ensure that patients are at the centre of the research. In this article, we will explore various innovative trial designs, their advantages, challenges, and real-world applications, shedding some light on the dynamic landscape of clinical research.

The Traditional Clinical Trial Paradigm

Clinical trials have historically followed a fixed and sequential structure. In such trials, researchers define a study protocol and then enrol participants following those strict criteria. This rigid design often makes it challenging to adapt to new information, resulting in inefficiencies, wasted resources, and delays in bringing effective treatments to patients.

In recent past, the landscape of clinical trials looked significantly different. Paper Case Report Forms (CRFs) were the norm, with research data painstakingly recorded by hand. This paper-based approach, while reliable, was not without its challenges. It often resulted in cumbersome data entry, transcription errors, and delays in data collection and analysis. Furthermore, monitoring the progress of trials involved on-site visits by the Clinical Research Associates (CRAs), which could be resource-intensive and time-consuming for all parties involved.

Whoever hasn't transported a pile of "data collected" CRFs in their car trunk may not understand the monitoring era I'm referring to.

Data management was also a labour-intensive process, often requiring meticulous attention to detail and multiple rounds of data reconciliation.

The Rise of Innovative Trial Designs

Innovative trial designs encompass a range of methodologies that break away from the traditional mould. These approaches embrace flexibility, adaptability, and efficiency, allowing researchers to learn from each patient's experience, update trial parameters, and optimise the research process.

The shift to innovative trial designs represents a departure from these traditional practices, embracing electronic data capture, real-time monitoring, and adaptive strategies that streamline the research process, enhance data quality, and bring us closer to the goal of more patient-centric and efficient clinical trials.

Here are some brilliant examples:

1. Adaptive Trials

Adaptive trials are designed to evolve in real-time based on the data collected. and then enrol participants following those strict criteria. This rigid design often makes it challenging to adapt to new information, resulting in inefficiencies, wasted resources, and delays in bringing effective treatments to patients.

In recent past, the landscape of clinical trials looked significantly different. Paper Case Report Forms (CRFs) were the norm, with research data painstakingly recorded by hand. This paper-based approach, while reliable, was not with- out its challenges. It often resulted in cumbersome data entry, transcription errors, and delays in data collection and analysis. Furthermore, monitoring the progress of trials involved on-site visits by the Clinical Research Associates (CRAs), which could be resource-intensive and time-consuming for all parties involved. Whoever hasn't transported a pile of "data collected" CRFs in their car trunk may not understand the monitoring era I'm referring to. Data management was also a labour-intensive process, often requiring meticulous attention to detail and multiple rounds of data reconciliation.

2. Umbrella Trials

Umbrella trials, on the other hand, focus on a single disease or condition but test multiple treatments within that umbrella. This design is particularly effective when dealing with diseases that are highly heterogeneous, enabling researchers to identify the most suitable treatment for individual patients.

3. Basket Trials

Basket trials focus on specific genetic mutations or biomarkers rather than the location of the tumour. This approach allows researchers to test multiple treatments simultaneously on patients with different cancer types but the same genetic mutation. Basket trials provide a more patient-centred approach, as they match treatment to the genetic makeup of the patient.

4. Platform Trials

Platform trials are master protocols designed to investigate multiple treat- ments for a specific disease. They have the advantage of continuously enrolling patients and testing multiple treatments concurrently. As one treatment arm concludes, a new one can begin, ensuring that the trial remains dynamic and efficient.

Real-World Applications

The impact of innovative trial designs is best understood through real-world appli- cations. Several notable examples have showcased the power of these modern methodologies. Each of these trials aims to address specific medical challenges, introduces innovative approaches, and offers unique benefits, along with their own set of challenges:

1. The I-SPY 2 Trial

ClinicalTrials.govIdentifier: NCT01042379

(see Figure: 1)

Aims: The I-SPY 2 trial, designed for breast cancer, aims to accelerate the development of effective treatments for breast cancer by evaluating multiple treatment regimens in the neoadjuvant setting. The primary goal is to identify and advance treatments that demonstrate the most promise.

Innovation: The trial's adaptability is its hallmark innovation. It allows for real- time assessment of treatment efficacy, enabling the removal of less effective treatments and the introduction of promising ones as the trial progresses. This approach reduces the time required to bring effec- tive treatments to patients.

Benefits: Patients receive potentially more effective treatments in a timelier manner. The trial optimises resource utilisation by minimising the need for lengthy, separate trials for each treatment, and it accelerates decision-making for drug development.

Challenges: The adaptability of the trial necessitates rigorous statistical methods to account for changing treatment arms. Ensuring informed consent and ethical considerations regarding changes in treatment plans are ongoing challenges.

2. The National Lung Matrix Trial

ClinicalTrials.gov Identifier: NCT02664935

Aims: This umbrella trial for non-small cell lung cancer aims to match patients to targeted therapies based on specific genetic mutations. It personalizes treatment by identifying and offering treatments tailored to each patient's unique genetic profile.

Innovation: The trial's innovation lies in its personalised medicine approach, which maximises the likelihood of therapeutic benefit for patients. It shifts the focus from one-size-fits-all treatments to precision medicine.

Benefits: Patients benefit from treatments that are more likely to be effective for their specific genetic makeup. The trial minimises exposure to ineffective treatments, reducing potential side effects and optimising resource allocation.

Challenges: Identifying and enrolling patients with specific genetic mutations can be challenging. Coordinating a trial with multiple targeted treatment arms can be complex.

3. The REMAP-CAP Trial

ClinicalTrials.gov Identifier:NCT02735707

(see Figure: 2)

Aims: During the COVID-19 pandemic, the REMAP-CAP trial aimed to improve outcomes for critically ill COVID-19 patients. The trial's adaptability allowed it to quickly test multiple treatments, including novel therapies, as the pandemic evolved.

Innovation: The trial's innovation lies in its rapid adaptation to the evolving needs of the pandemic. It provides a platform for testing a wide range of treatments simultaneously.

Benefits: The trial helps identify effective treatments and improves the chances of survival and recovery for critically illCOVID-19 patients. It reduces the time needed to assess the effectiveness of potential treatments.

Challenges: Adapting the trial to a rapidly changing situation requires swift deci- sion-making and coordination. The large amount of data generated and the need for real-time analysis can be challenging.

4. The NEJM Catalyst Innovations in Care Delivery

Aims: The NEJM Catalyst Innovations in Care Delivery initiative aims to show-case innovative trial designs and their impact on healthcare delivery and patient outcomes. It serves as a platform for sharing and disseminating insights into new approaches to care.

Innovation: The initiative itself is innovative in that it regularly highlights novel approaches and methodologies that enhance patient care delivery. It acts as a bridge for sharing best practices and innovative strategies.

Benefits: The initiative benefits healthcare professionals by providing a platform for learning about and adopting innovative approaches to care delivery. It contributes to the dissemination of best practices and innovations in the field.

Challenges: While the initiative doesn't conduct clinical trials itself, it faces challenges related to the evaluation and validation of the approaches it showcases. Ensuring that featured innovations are evidence-based and effective is crucial.

These real-world applications of innovative trial designs illustrate the diverse aims and innovations that can be achieved through modern clinical research methodologies. While they offer significant benefits, they also come with unique challenges, underscoring the need for ongoing adaptation and innovation in the field of clinical trials.

Benefits of Innovative Trial Designs

The adoption of innovative trial designs offers a multitude of benefits, transform- ing the clinical research landscape:

1. Accelerated Drug Development

Innovative trial designs enable faster decision-making by allowing for adap- tive changes. This acceleration of the drug development process is critical, especially in the context of emerging diseases or urgent medical needs.

2. Resource Optimisation

Traditional trials often suffer from resource waste due to inefficiencies. Innovative designs allow for efficient resource alloca- tion, reducing the overall cost of research.

3. Enhanced Patient-Centricity

Innovative trials prioritise patient needs by matching treatments with genetic profiles or adapting to patient experiences. This patient-centric approach contributes to better outcomes and improved patient satisfaction. A great example of patient-centred approach are the Decentralised Clinical Trials. DCTs are a modern approach to clinical research that leverages technology to conduct trials with minimal reliance on physical sites, such as traditional hospitals or clinics. These trials aim to bring the research directly to patients, often in the comfort of their homes. There are some undeniable key benefits of DCTs, particularly in the context of a patient-centred approach, such as DCTs prioritise patient convenience and comfort by allowing participants to engage from their homes, reducing the need for frequent site visits. DCTs also improve access and inclusivity by removing geographical barriers, enabling individuals in remote areas or with limited mobility to participate. They attract a more diverse pool of participants, leading to a better understanding of treatment effectiveness in different demographics. Patients in DCTs experience reduced travel, shorter wait times, and a flexible schedule, which is especially beneficial for those with chronic illnesses or ongoing treatment. Real-time data collection through remote monitor- ing enables researchers to access timely information on participants' health, treatment adherence, and potential side effects. DCTs also optimise resource utilisation by requiring fewer physical infrastructure and staff, resulting in cost savings and more efficient trial execution.

Despite all the benefits, there are still some challenges that need to be addressed in order to make the modern conduct of clinical research even more efficient. These challenges include ensuring data security and privacy in a decentralised environment, addressing technology access and literacy disparities, navigating regulatory hurdles, ensuring the quality of data collected remotely, maintaining participant engagement and adherence to trial protocols, addressing ethical considerations in decentralised trials, and implementing robust risk management strategies. As the field of clinical research continues to evolve, overcoming these challenges is essential to fully leverage the potential of DCTs.

4. Improved Data Quality

Real-time adaptability allows researchers to refine trial parameters, resulting in more precise and valuable data.

Challenges and Considerations

While innovative trial designs offer many advantages, they also come with their own set of challenges and considerations:

1. Regulatory Complexity

Regulatory bodies are still adapting to these new trial designs, which can create hurdles in approvals and compliance.

2. Statistical Rigour

Innovative designs require robust statisti- cal methodologies to account for adap- tations and multiple treatment arms.

3. Data Sharing

As these designs involve larger and more complex datasets, data sharing and transparency become increasingly important.

4. Ethical Considerations

Patient consent and the potential for changes in treatment arms pose ethical considerations that must be addressed.

A Promising Future:

ELEM Biotech

A significant step towards fostering innovation in clinical research is the recognition by regulatory bodies, such as the FDA, that in some cases, animal testing may no longer be necessary. This paradigm shift acknowledges the ethical concerns surrounding animal testing and the advancement of alternative methodologies, such as in vitro testing and computational modelling. By reducing the reliance on animal models, clinical research can become more ethical, efficient, and patient-centric. This shift not only accelerates the drug development process but also aligns with the principles of innovative trial designs by prioritising the welfare of both patients and animals. It represents a promising future where scientific progress and ethical considerations can coexist harmoniously in the pursuit of medical advancements.

ELEM Biotech is pushing the boundaries of innovation with a groundbreaking approach that introduces virtual humans into the world of clinical trials.

Pioneering the Future of Clinical Trials...

*This article is part of Pharma Focus Asia Magazine 's issue 54. If you'd like to read the full article, click on the link below:

https://www.pharmafocusasia.com/clinical-trials/innovative-trial-designs-revolutionising-clinical-research

Also, don’t forget to subscribe for The CRA Wizard’ newsletter here, or checkout the blog here ✌️

We've all been there - the CRA interview prep can be intimidating and sometimes even scary. It does get a little bit better with time and experience gained through your work in the field. However, the uneasy feeling of the unknown, what you will be asked, or whether you will respond correctly to scenarios, somehow always remains.

Since I launched The CRA Wizard Academy and started my consulting business, where I help people pursue a career in clinical trials, I realized that the most common questions I've been asked by friends and strangers are how to prepare for a CRA (or equivalent) interview, how to build their CV, or how to develop and scale their LinkedIn profile for better success with recruiters. So, I have decided to write an article about it.

💡

If you need a clinical research career advice book a slot from here.

This article serves as a comprehensive guide to prepare one for a CRA interview. I understand that the process can be somehow intimidating, especially if this is your first CRA interview that you have finally managed to land. Therefore, I have provided some advice, Q&A examples, and scenarios that you may encounter throughout your career. And if you would like to read more about how to land a CRA interview, check out my previous article here.

Also, I understand that most of you don't have interviews every other day, and this article could be forgotten. So, make sure to save the article for later, or for whenever you need a recap.

I have provided answer examples below; however, I do encourage you to be as sincere as possible with your own answers! In my opinion, being straightforward and truthful is the best strategy for any interview and great communication practice in general! This leaves no room for guessing or interpretation and will save time and potential disappointment for both you and your potential employer.

Research the background and values of your desired company

This is your starting point. Begin by conducting research on the company, if you haven't already done so when applying for the position. Read about the company's pipeline to determine which therapeutic areas they focus on the most. If you have relevant experience in any of these areas, it's a good opportunity to mention it 😉.

You may also be asked about specific company values and how you understand them. Prepare to provide an example from your job where you followed one of the company's values.

Try to use an example that aligns with the values you have researched. Think about how you can implement it in a work-related situation that required strong problem-solving skills on your part.

In the example below, I have used the imaginary value "We put patients first" and incorporated it into an imaginary situation:

Here is an example for patient safety: There was a time when one of the subjects in one of my sites experienced a Serious Adverse Event, which led to myocardial infarction. The subject became unfit for the study due to an IMP-related SAE. However, the Sponsor insisted that the Principal Investigator change her mind about the subject's eligibility in the study, which could have compromised patient safety.

How did I handle it (keeping in mind the value)? I had a lengthy discussion with the Principal Investigator to fully understand her concerns. Afterwards, I discussed it with the medical monitors. We then had a conversation with the Sponsor's safety team. During the conversation, the safety team repeatedly insisted that the PI amend her assessment and continue the patient in the trial. I supported the investigator and helped her explain her reasoning. Additionally, I reminded the safety team that patient safety should always come first. Keeping the patient in the study would have put her overall well-being at risk, when the risks outweighed the benefits of the study drug. Therefore, we did not wish to compromise both patient safety and the overall study results in that manner.

Questions your interviewer may ask you

Next, there are always generic questions that are likely to be asked in any interview, not just limited to clinical trials. As simple as they seem, they are also the starting point for your conversation with the interviewer. They will set the tone and help establish a connection during the interview. These questions are essential, and it is best to anticipate them and already have prepared answers. This way, you can avoid thinking out loud during the interview and ensure that you present yourself in the best possible way. The better prepared you are, the less likely you are to say something out of context that could negatively impact your chances.

Here are some examples of such questions, along with the answers I would have provided. However, keep in mind that this will vary between different companies and may not always be applicable. As usual, there is no one-size-fits-all approach.

Q: Why do you want to work for company X?

Answer: Company X is a multinational pharmaceutical and/or biopharmaceutical company renowned for its contributions to the healthcare industry. Here are some key aspects for which X is known:

1. Pharmaceutical Innovation: X is recognized for its dedication to research and development, resulting in the discovery and development of innovative drugs and treatments in various therapeutic areas.

2. Global Presence: The company has a strong global presence, operating in multiple countries and collaborating with healthcare professionals, researchers, and organizations worldwide.

3. Focus on Chronic Diseases: According to your pipeline, X is particularly known for its focus on chronic diseases, including cardiovascular diseases, respiratory conditions, oncology, rare diseases, and diabetes.

Taking that into consideration, I would like to be part of the team, as the company's reputation and presence strongly resonate with what I see as my purpose, and I would love to work in a similar-minded environment.

Q: Why are you interested in the CRA role?

Answer: The role of a CRA is highly responsible and dynamic. As a CRA, our job is to serve as the intermediary between the sponsor and the investigational site. We ensure that the clinical trial is conducted with the utmost standards of quality, safety, and compliance. Our monitoring activities play a vital role in maintaining data integrity and ensuring patient safety throughout the trial. Sometimes, we do handle unexpected challenges and put out fires. These aspects of the role motivate and drive me, and I look forward to career progression in the future.

Q: Why do you want to change companies?

Answer: Here is crucially important, to NOT TRASH YOUR PREVI0US EMPLOYER! Seriously, I mean it, I would have thought this is a no-brainer, however, you would be surprised by the amount of people failing interviews, because they have been disrespectful towards their ex boss.

Instead, I would advise you to explain your reasons calmly and respectfully. Try to be as sincere as possible, but also detach from any personal feelings you might have towards your previous company. Instead, focus on processes and what you would like to improve in the future. You could say something like: "I was presented with a fantastic opportunity, and I am delighted to have the chance to meet you and discuss this with you. Your company is a great place to work, and I am excited to be considered as a potential addition to your team.”

Job specific questions

Q: Describe a situation where a patient does not meet one or more of the inclusion/exclusion criteria – how would you handle this?

Answer: The main goal of clinical trials is to prove that a medication is safe and effective when used by the target population it was designed for. In general, if a subject does not meet an inclusion criteria, they are not eligible for the study. However, depending on the study specifics, this could be reviewed on case by case basis - lets say there is some wiggle room in the protocol e.g mentioned exceptions which could be confirmed by the medical monitor - in this situation it is always worth the try to review the particular case and unmet criteria with the Medical Monitor, as the values may come extremely close and again, depending on the study, the MM may be able to provide a waiver, considering the patient safety as a priority of course an the benefit outweighs the risk.

Q: How do you prepare for an RMV?

Answer:

1. Review Study Documents: Familiarize yourself with all study-related documents, including the protocol, investigator's brochure, study manual, and monitoring plan. Ensure you understand the study objectives, procedures, and requirements.

2. Study Site Information: Gather detailed information about the site you'll be visiting, such as its location, contact details, and the names of the principal investigator and key site staff.

3. Review Site Performance: Assess the site's performance and enrollment progress before the visit. Review the site’s enrolment plan. Check if there have been any outstanding issues or deviations that need to be addressed during the monitoring visit, or outstanding such form previous visits.

4. Monitoring Visit Schedule: Coordinate with the site staff to establish a suitable date and time for the monitoring visit. Make sure all relevant personnel, including the investigator, sub-investigators, and study coordinator, are available during the visit. Bring comfortable shoes, just in case you have to chase the PI down the whole 😁.

5. Prepare Monitoring Tools: Assemble all necessary monitoring tools, including the case report forms (CRFs), data validation checklists, and any study-specific monitoring worksheets.

6. Data Management System: Ensure that you have access to the data management system or electronic data capture (EDC) platform to review study data remotely or on-site if applicable.

7. Prepare Monitoring Plan: Develop a monitoring plan tailored to the specific study and site, outlining the areas to be assessed, data to be verified, and any specific focus points.

8. Travel Arrangements: If the site is located away from your regular workplace, arrange travel and accommodation well in advance to ensure a timely arrival for the monitoring visit.

9. Regulatory Documents: Check that all regulatory documents, such as ethics committee approvals, informed consent forms, and investigator CVs, are up-to-date and available for review. Check if there are any recent protocol amendments, ICF updates etc.

10. Investigational Product: Ensure that the investigational product (IMP) is appropriately stored and accounted for at the site. Verify that there have been no issues with IP management and compliance.

11. Checklist and Compliance: Prepare a monitoring visit checklist to ensure you cover all necessary aspects during the visit, including data verification, regulatory compliance, and adherence to the protocol.

12. Communication: Inform the site staff about the upcoming monitoring visit and its purpose. Clarify any expectations and address any questions or concerns they may have.

13. Coordinate with Sponsor: Communicate with the study sponsor to share the visit schedule and discuss any specific topics or areas of interest for the visit.

14. Personal Readiness: Make sure you are well-prepared, organized, and have all necessary documentation and materials ready before heading to the site. Always bring a pen and sticky notes, you will thank me later.

15. Additional Preparations: Depending on the study and site-specific requirements, you may need to prepare for specific aspects such as central lab result reviews, serious adverse event reconciliation, or protocol deviation investigations.

Q: How do you deal with a “difficult investigator”?

A: I once had an investigator who perceived me as too young and inexperienced and didn't take me seriously. From that point on, I had to strive for perfection - I couldn't be five minutes late for a meeting, I had to provide the right guidance each time, and I couldn't say "I don't know, I'll check and get back to you" (which is an absolutely valid response by the way) - I simply had to be perfect. I learned to adapt to his communication style and keep it professional.

Now, I am his favourite CRA, and he does not want to work with anyone else.

Throughout my career, I have experimented with different approaches to communicating with my site teams. I tried being extremely professional, keeping communication strictly official. I also tried being more friendly to build better trust with my teams. However, I discovered that there is no perfect recipe for building a good relationship with your site teams. It's more about adapting to their communication patterns and letting them take the lead.

Questions to ask your future employer:

Keep in mind that a job interview is a two-way street. You are not only being interviewed by your future employer, but you are also interviewing them. This is your chance to learn more about the company you want to work for and gain knowledge about clinical trials in general. This will help you imagine yourself in their team and ultimately, to make your final decision.

And even if the interview doesn't go well, the interviewer will likely provide feedback on where you went wrong, giving you an opportunity to improve in the future. So, don't hesitate to ask questions about anything that interests you.

Q: What would my daily responsibilities be?

It is crucial for you to know the specific tasks and duties you would have on a daily basis. Although I am now an experienced CRA, the responsibilities can vary between different CROs/Sponsors. Therefore, I always inquire about the details of the role I am being considered for. For example, I ask about the structure of the team, the phase/therapeutic area of the potential studies; extent of travel required, the deadlines for drafting and finalizing reports, and whether it is a single or multi-sponsor dedicated position. These questions can provide you with valuable information about the job you will be doing. For example, let’s say you are being told you will work predominantly on phase II studies. Phase II typically focus more on IMP safety profile, which involves a significant amount of safety procedures being placed for the subjects, collection and evaluation of PK samples, and frequent patient visits as outlined in the protocol. As a result, you can deduct that you will need to be more vigilant in identifying safety-related deviations, due to the complicity of the protocol, there will be more room for error; subject visits will be more frequent; you will travel more frequently for on-site visits, and have less time for reporting, e.g the deadlines for reporting will be tighter etc. Phase II studies are more reactive and require a high level of attention to detail.

Q: How would you describe the company culture? What makes you enjoy being part of the team/company?

The company culture is of utmost importance. It is preferable to work with bright, ambitious, and positive individuals, so the work culture matters greatly. Personally, I appreciate a forward-thinking and innovative environment where new ideas are welcomed. Therefore, I ask questions such as "how would you describe the company culture?" and "what value do your colleagues bring to your work?" In general, I am interested in knowing if there is room for introducing new ideas. So, make sure to identify which part of the company culture is important to you and inquire about the company's stance on that.

Q: Is the team based remote or at the office?

Last but not least, in todays’ world where everything is more and more thriving towards the digital and location independent, it is extremely important for me to have the option to work fully remote. I don't believe in the recently created "hybrid" work situationship, which involves something of the sort three days at the office and two days from home for most companies. Let me explain why. It has nothing to do with my productivity - I'm more or less equally productive, regardless of where I work from. I believe that the hybrid solution is not ideal, as it implies a lack of trust in the team's ability to work remotely. This raises the question of why you would hire people with questionable work ethics whom you have to micromanage for at least three days per week. Even if you comply with the rule, you may find that your colleagues have decided to work from home that day, making the whole idea of being at the office redundant.

Personally, I prefer to work from home, where I have a dedicated home office space (house 🐍 Slytherin here). I find it less distracting, as I'm not interrupted by anyone, furthermore, I don't waste time on coffee breaks or getting ready for work or commute. It's just a lot calmer, and I appreciate that.

That being said, I really admire my colleagues, and working at PSI CRO is an incredible experience, largely thanks to the company's transparent, relaxed, and easy-going culture. I genuinely enjoy my time in the office as it allows me to connect with my colleagues. However, personally, going to the office holds more of a social aspect for me. And the PSI CRO parties are absolutely fantastic! 😁 👌🏿

PSI CRO’s 28th birthday in November 2023.

Anyway, it is important to ask about the requirements related to remote work during your interview.

Final advice

Interviews are similar to first dates in many ways. So, it may sound like a cliche, but try to be the most authentic and sincere version of yourself while remaining professional. Don't try to pretend to be someone you're not just to impress and secure the job. Ultimately, you won't be able to keep up the facade forever and you'll end up in a place where you're not happy, doing a job that doesn't bring you fulfilment.

Good luck on your interview! I'm confident that you will do great! 👊

Finally, if you'd like additional preparation before your interview, feel free to book a slot with me here. We will go through all the details together, conduct a mock interview, and ensure that you are fully prepared for anything that comes your way on the path to your dream job!

What is a “Burnout”?

So, let's briefly discuss what burnout is. Here is the definition: "Burnout is a state of physical, emotional, and mental exhaustion often caused by prolonged periods of chronic stress and overwork. It is typically associated with work-related stress but can also result from other sources of stress, such as caregiving or personal life challenges."

Here, I'd also like to add that the term "burnout" is often used to imply the need for a break - a cup of tea, a long weekend in the mountains, or a tropical vacation. While each of these is beneficial on its own, especially when you're tired and in need of self-care, burnout is a different matter. Burnout is typically a condition where a cup of tea or a brisk walk in the mountains won't alleviate the darkness. Once symptoms of burnout begin to appear, it's too late for prevention. In Bulgaria, we say “Late love for a braid” or “Късно либе за китка”.

Burnout is much more serious than simply feeling tired after a long week. Below, I have tried to summarize what burnout may feel like, although this can vary for each individual. I would also like to mention that I have never personally experienced a deep, full-blown burnout sensation. However, there have been several occasions in my career/life where I have come close to it and noticed the symptoms relatively early.

Dear clinical research professionals, If you find yourself experiencing any of the symptoms below, it might be time for an intervention:

1. Physical Fatigue: You might feel physically drained and may experience symptoms like headaches, muscle tension, and general weakness. Your energy levels are consistently low, making it difficult to get through the day. Heck, some days it's incredibly tough to even get off the couch.

2. Emotional Exhaustion: Burnout can lead to feelings of profound emotional exhaustion. You might become increasingly detached from your work or personal life, feeling numb or indifferent. You may also experience heightened irritability, mood swings, or a sense of hopelessness.

3. Cynicism and Detachment: You may start to develop a cynical attitude towards your work (I know, sarcasm is a bliss, but cynicism is another story) or the tasks that once interested you. This often involves a sense of emotional detachment, where you no longer care about the outcomes.

4. Reduced Performance: Burnout can have a significant impact on your performance and productivity. It can make it difficult for you to focus, make decisions, and complete tasks efficiently. This will become extremely evident in your work. As we all know, the CRA role is demanding and requires the ability to work under pressure, some wicked problem solving and time management skills. Experiencing burnout will make it impossible to meet these requirements.

5. Sense of Ineffectiveness: You may feel like your efforts are in vain or that you're no longer able to meet your personal or professional goals. This can lead to a decrease in self-esteem and self-worth. This is also a great point for imposter syndrome to kick in, or at least mine does, reminding you of all your insecurities and unresolved self-worth issues. Our minds have this spectacular tendency to kick you while you are down, in an effort for self-preservation. Lovely feeling.

6. Loss of Motivation: This is the most evident symptoms of all - burnout often leads to a loss of motivation and passion for the things that once interested you. You might find it challenging to find joy or satisfaction in your work or other aspects of your life.

7. Physical Symptoms: In addition to the physical fatigue mentioned above, burnout can also manifest with physical symptoms like sleep disturbances, changes in appetite, and increased susceptibility to illnesses or a total immune failure.

8. Social Withdrawal: You might withdraw from social interactions, including spending time with friends and loved ones, as you may lack the energy or desire to engage in social activities. Social withdrawal from people or activities that used to bring you joy is also very common. Sadly, those are precisely the thing that will help you recover from this state.

9. Feeling Overwhelmed: Burnout often makes you feel overwhelmed by even small tasks. The sense of being unable to cope with daily responsibilities can be debilitating.

Burnout is a gradual process that doesn't happen overnight, but can creep up on you. The signs and symptoms may be subtle at first but become worse over time. Consider these early symptoms as major red flags indicating that something is wrong and needs to be addressed. By paying attention and actively reducing your stress, you can prevent a major breakdown. However, balancing work, progressing in your career (especially in a competitive field like clinical trials), maintaining a good work-life balance, nurturing relationships, staying active, seeing friends and family, and practicing self-care can be challenging. I understand that it's easier said than done.

Why and when burnout happens?

As we all know, the clinical research field is extremely competitive and fast-paced. From breaking into the industry to managing daily responsibilities and staying up-to-date with trends, it can be challenging to excel in this line of work. Burnout is experienced in all areas and industries, but there are specific factors that are unique to our industry due to the nature of the work environment. While it is difficult to pinpoint a single thing that will push you over the edge of burnout, here are some aspects where burnout may originate in the field of clinical research:

Toxic work culture

A toxic company or toxic work culture can be the biggest contributor to employee burnout. I have divided them into several minor factors, which I classify as a toxic work environment in different aspects.

High Workload: Clinical research can be demanding, with tight deadlines and numerous responsibilities. CRAs often need to manage multiple projects simultaneously, resulting in long working hours, frequent on-site visits and reports, meeting study deadlines, enrolment challenges for each project, and overall high stress levels.

In my opinion, the role of a CRA should not be fulfilled to maximum productivity, such as working 8 hours per day or 40 hours per week. Let me explain why - the CRA role is highly specific and dynamic in nature. CRAs are not only required to travel extensively, when this alone can lead to unpredictable situations like flat tire, traffic jams, road closures, or accidents, which cannot be confined to a 9 to 5 schedule. Once it took me twice the usual time to reach the site, all because of heavy snowfall in the mountains and the fact that I didn't have tire chains. It would have been much faster if I had snowboarded to the site; no carrying space for the OSF on my snowboard however.

Of course, I am well aware of the argument that most employers will respond with: they do not wish to pay a full-time salary to someone working at only 60% capacity. I understand. However, this is not a black and white matter. Very often, CRAs are required to work more than 40 hours per week or exceed 100% capacity. While this is even encouraged in some companies, there are no compensations offered for overtime, not even a pat on the shoulder. Therefore, I believe that once the final timesheet breakthrough comes, the employees are still covering their productivity objectives.

Long and Unpredictable Hours: Being a CRA can involve irregular and long working hours, especially during clinical trials or data collection phases. The unpredictability of work schedules can fairly easily disrupt your so well laid work-life balance. However, as a CRA, you are required to immediately (if not sooner) resolve certain urgent tasks that may arise unexpectedly, such as, but not limited to: SAEs & SUSARs or any patient safety concerns; database cleaning & lock; site staff turnover; unscheduled visits; protocol deviations; study audits & inspections and all sort of site emergencies (let’s not forget about the PI and his Medidata forgotten password).

With that being said, I do admit that there are CROs, that are able to manage the workload for their clinical research associates far better than others (a big shout out to PSI CRO AG CRO AG for understanding and managing this need so well). However, I do have close friends and colleagues who are traveling on site visits 18 out of 20 work days per month. Maintaining such a schedule is dooming both the whole project and the CRA responsible to failure, as this is the fastest track to being unable to juggle all your tasks and not meeting the project milestones, due to constantly being in the field.

Toxic project managers: This is a really important one. I have to admit that throughout my modest career, I have almost never faced a challenge with a "toxic" manager. It's quite the opposite-almost all of my managers have been amazing professionals and mentors whom I look up to.

However, the situation with a toxic manager is painfully familiar to many people, and it is usually the original cause of CRA burnout, switching companies, and in some cases, even professional careers. Remember, people never really leave certain positions but rather toxic work environments. For the most part, it is up to the managers to create a positive work environment.

I have been in situations where, at some point, I felt extremely frustrated, overburdened, and mostly unheard by my manager. I'd like to add to this part that communication with other people is often the most challenging part of the job, regardless of the field. This could happen in both online or face-to-face communication (there are things that could be left unintelligible in both types) and could leave the other person with a bitter feeling after the conversation, simply because you did not express yourself properly, or the other party understood something completely different. In many cases, you could just be lost in translation. Or in rare occasions, the manager could simply be an arse 🤷♀️.

I would advise you to adopt a straightforward approach to things. If you dislike something, bring it up, discuss it, come up with an action plan, and try to resolve it. However, this approach may be outside the comfort zone for many people, who may instead engage in what is called "quiet quitting."

• If you are interested to learn more about "quiet quitting," click here.

• *And if you are interested in reading a practical step-by-step guide on dealing with difficult managers, check out my other article here.

Pressure to Publish: In academia and research institutions, there is often a significant emphasis on publishing research findings. The pressure to produce publishable results can be intense, leading to stress and burnout. This is especially valid for clinical trials investigators who are working on publications or at stages in their careers where they are trying to build their name and reputation.

Isolation and working form home

I am personally a big fan of working from home, as long as it is done correctly and you possess the necessary work ethic and self-discipline to actually perform your job, while no one is watching 😉

Working from home is a blissful experience that was adopted mostly due to the not-so-blissful consequences of Covid-19. I truly believe that this is the future, and modern society is moving closer to location-independent work.

However, like everything else, remote work can become tricky, especially for people with more introverted tendencies. Going to the office, as dreadful as it was, came with a lot of experiences associated with that activity, such as making friends at the office, visiting a certain coffee shop or restaurant in the area, and perhaps going to the nearby gym or having your kids attend the nearby school.

Now, with remote work, you no longer have all these reasons to leave your house. This means that you are more prone to isolation if you don't take the initiative to go out and do stuff. It requires a little bit of extra effort, but at the same time, it is so rewarding to find and dedicate time in your day to go outside, socialize (moderately is enough, after all, socialization is overrated 😛), see some sunlight, and get some physical activity.

Sleep depravation and physical health

Studies have shown many times that sleep deprivation and the lack of physical exercise are proven to be the biggest factors not only for burnout, but also for even more severe mental conditions, like depression, anxiety, and panic attacks.

Did you know that one study proved that driving when sleep deprived is even more dangerous than drunk driving? Now imagine what chronic lack of sleep does to your body and mental health. I feel I cannot stress enough how important sleep is, and how underestimated it is at the same time. Sleep affects all aspects of your life and has a direct effect on your productivity and motivation at work.

• An awesome book that explains the importance and mechanism of sleep is "Why We Sleep?" by Matthew Walker.

And this brings me to my next point - EXERCISE!

Now, the level of physical activity in which you might wish to engage is very different for everyone. For some people, a brisk walk in the park twice a week may be enough. However, for others (like myself), anything less than heavy workouts like CrossFit or HIIT 7 times per week, combined with lighter workout activities such as walking, yoga, running with the dog, or hiking, and of course, some extreme sports like kitesurfing, snowboarding, mountain-biking is just insufficient. However, the point here is NOT to become an Olympic champion in any discipline, but to engage in enough moderate activity to maintain your sanity 😉. This can go a long way, especially in preventing burnout.

How can CRO’s prevent their employee burnout?

Preventing employee burnout in CROs is crucial for maintaining a productive and healthy work environment. Here are some strategies, which I believe could help to achieve this:

Thoughtful Management Selection

Selecting the right individuals for management positions is crucial. Just because someone is a good employee, meeting their KPIs or whatever, does not necessarily mean they will be good managers. In my experience, people management is often the most challenging aspect of any job, and it is a skill that can be acquired like any other. Without acquiring the necessary skills and training for management, you are setting your team up for disaster. Managers should possess strong leadership skills, empathy, patience, vision, and the ability to support their teams when sh*t hits the fan. They should also be able to recognize signs of burnout and provide guidance and resources to address it.

Workload Management

Balancing workloads for clinical research professionals is crucial. CROs should ensure that employees are not consistently overwhelmed with excessive work. Adequate staffing and realistic project timelines can help reduce stress and burnout, as well as facilitate meeting milestones and retaining valuable personnel within the company.

Kill the Micromanagement

Trust your employees to effectively perform the tasks they were hired for. If you don't trust them, then don't hire them in the first place. Micromanagement can lead to frustration for both parties and ultimately create a dreadful work environment. Provide professionals with the autonomy to manage their responsibilities, as long as they meet project goals and quality standards.

Values-Driven Work Culture

Focus on creating a work culture that embraces meaningful values and principles. This includes being part of a bigger cause, promoting work-life balance, and investing in the development of our people. When employees believe in the purpose and mission of their work, they are more likely to feel motivated and fulfilled. Remember, the focus of our work culture is on shared values and a common mission, not just on having free pizza in the office.

What can YOU do to prevent burnout?

Exercise

As I have already mentioned, staying active and getting enough exercise is crucial for your mental and physical health. And both aspects are strongly connected. Exercise helps reduce stress, releases "happy" hormones, elevates your mood and keeps you fit (for carrying loads of monitor folders for your next on site visit).

Drink water

It may sound cliché, but staying hydrated is important for all physiological needs of your body, as well as for your mental health. So remember to drink water.

Stop drinking alcohol

I understand that this statement may trigger some people, and those who know me personally know that I often discuss the downsides (as there are no positives) of drinking alcohol. Hear me out - alcohol has become so normalized in today's society, especially in Bulgaria, that as soon as you find yourself in a social setting and refuse a drink, people start asking if you are sick. Take a moment to let that sink in. There is a social stigma on marijuana and other drug substances, but at the same time, drinking alcohol has been glorified and associated with fun, even though alcohol may have even more severe and long-lasting negative effects on your health. And no, not even one glass of red at dinner is beneficial for your heart, this is bullsh*t.

I won't engage in a lecture on why alcohol is bad. However, if you are interested in the topic or would like to learn more, check out Andrew Huberman's podcast on "What Alcohol Does To Your Body, Brain & Health”.

While alcohol may seem like a great way to manage stress, it actually does the exact opposite - it increases it. Alcohol is also responsible for dopamine spikes, followed by dopamine lows, during which you feel even worse than before drinking. It also has a tremendous negative impact on your sleep, as the quality of the sleep you get is actually a lot worse than when you do not drink. Alcohol also reduces cognitive function and makes you numb, which makes it harder to appreciate the simple joys of life.

Even moderate consumption of 1 glass of wine per day (which, by the way, is indeed classified as moderate drinking) will have negative health consequences, such as liver disease, impotence, and a weakened immune system in the long run. Needless to say, all these factors will definitely impact your mental health and increase the risk of burnout.

Minimize refine sugar intake

Maintaining a healthy diet is essential for mental health in general. However, if there is one single food supplement, that has a massive impact on your mental health, it is the strongest narcotic of all - sugar.

Since ancient times, our ancestors' and our own bodies were designed to always seek out the most sweet and fatty foods they could find. This was an essential mechanism for their survival, as in those uncertain times, they never knew when or from where the next meal would come (or if they would become the next meal themselves). That is why our bodies are naturally inclined to crave the comfort of sugary and fatty foods. This innate craving ensures our survival and satisfaction for as long as possible.

Unfortunately, in modern society, where we no longer hunt mammoths or run from beasts, the abundance of sugar and junk food high in fat has the exact opposite effect on our survival. Excessive consumption is not only the sole reason for cardiovascular disease and obesity, but it also significantly impacts our mental health. Some studies suggest that high sugar intake may affect the body's response to stress. Burnout is often characterized by chronic stress, and sugar consumption may exacerbate the physiological stress response. Refined sugar is associated with mood swings and increased feelings of anxiety and depression. These effects can worsen the emotional aspects of burnout.

Get plenty of sleep

I have already discussed this above. However, I want to add that sleep deprivation was used as a torture technique in the past, and maybe even nowadays, if you were unlucky enough to be detained in a non-government compliant prison located in a no-man's land. Why would you voluntarily torture yourself by staying up late watching a lame TV show or partying all night, only to feel like something dragged in by the cat on the next day?

Practice mindfulness

I know that some people, or at least I do, get this reaction like I want to vomit a bit in my mouth when someone says "practice mindfulness." But this was before I realized that I had a very wrong idea of what mindfulness is. Of course, mindfulness may come in the form of sitting cross-legged on the ground with your eyes closed, taking deep breaths for what seems like hours at a time. But it can also be anything really, that brings your focus inward, towards your own mind and thoughts. I find that self-reflection, identifying and acknowledging what you feel, and approaching stressful thoughts with curiosity rather than criticism, may be extremely helpful during hard times. Mindfulness can be practiced in various forms that help channel your thoughts towards resolving an issue. For example, I find it extremely relaxing and calming to listen to a book and reflect on myself while running or walking my dog, doing yoga, or listening to music or podcasts. Some people keep a journal, others write blogs. Writing is also a great tool to structure your thoughts and revise them until you gain a clear perspective on things.

Stay connected and focus on meaningful relationships

Staying connected and seeking friendship and advice when you are most vulnerable can be extremely helpful. It always helps to have someone to talk to. Sometimes we have the tendency to stay in our heads and obsess over an issue, making it feel like the end of the world. Having a trusted someone to share our negative thoughts with, can be extremely healing and provide a fresh perspective on the issues we are dealing with. You might even discover that you are not alone in your struggles. And we all know that shared struggles are half the struggle - that is why people enjoy group workouts.

Get a dog 🐕 (you can thank me later)

When I rescued my dog, I had no idea what I was getting myself into. Not even a clue. Getting a dog at 22 taught me discipline, taking responsibility, and caring for another being besides myself. Don't get me wrong - it comes with plenty of responsibilities. You need to be able to provide time, space, love, discipline, and dedication to your new furry friend.

But let me tell you - what you get in return is worth every destroyed couch, wall, pharmacology book, etc. (Perhaps, don't get a German Shorthaired Pointer unless you're up for an adventure). Your dog becomes your best friend, your partner in crime (literally), and adventure. They provide an endless amount of fun, playtime, and companionship. Ultimately, they give you a reason to get up and go on an adventure every single day. One simply cannot feel lonely or sad for long, if owning a dog (especially a GSP). In many ways, I believe that my dog was the one who rescued me. Despite the challenges, this was one of the best decisions in my life.

I mean, look at this fluffy face - it’s ADORABLE 😍 They call them emotional support dogs for a reason.

Finally, mental health and burnout are serious issues that should not be disregarded. If you find yourself in a situation where nothing else helps, please talk with friends and family, seek professional help, and do not feel ashamed to address the issue. I have had a very positive experience with the platform Better Help, as it is extremely convenient and you get matched with a therapist who suits your needs immediately. However, if professional help is something that you cannot afford, I strongly recommend reading some psychology and self-help literature. Here are my top personal favorites that came to mind, but I am sure there are many more good examples: • “The Subtle Art of Not Giving a F*ck: A Counterintuitive Approach to Living a Good Life” by Mark Manson • “Everything is F*cked: A Book About Hope” by Mark Manson • "Why has nobody told me this before?" by Julie Smith In conclusion, mental health and burnout are topics that I believe are not being discussed enough. While we are bombarded by images of people who seem to have it all on social media, it is easy to feel like you are the only one experiencing a difficult time. Trust me, you are not alone. We are all in this together. And as challenging as it may seem at times, things will get better if you have the courage to take action. As my favourite fish, Dori says “Just keep swimming” 😊

You all already know how my firs-ever went (dreadfully) so I won’t get into details (you could read the full article here). So, let’s dive in.

Audits are an essential part of quality management. Also, I believe that working with external auditors ensures you avoid conflicts of interest and provide an independent perspective.

Why do so many companies panic when a major audit is due? In many cases, the root cause is their continual underinvestment in quality, or even negligence in some cases. This results in staff having to rush around to patch things up before the auditor arrives.

This "sticking plaster" approach is counterproductive because it risks exposing the company's lack of quality monitoring. Instead, companies should embrace providing a high-quality service, because essentially, monitoring is what we do, and data quality and integrity are the products we bring to the table. We should aim for perfection at all times rather than only chasing it a week prior to the audit.

So, how can you prepare yourself and your site to interact with the auditor? Let's take a look!

DON'T - Overshare information

I feel like this should be a no-brainer, but common sense isn't always that common. With that being said, it's very common for the CRA (or the investigator - be sure to prepare your site well) to try to be as open and transparent as possible, and to help the auditor see what a great job the site has done. However, this often leads to oversharing information that no one asked for. This is dangerous as you may reveal something that you should not have said (e.g. unnecessary details, which could come back to bite you) or simply annoy the auditor and give them more possibilities to find something that they otherwise would not have focused on. So, keep your details to yourself unless specifically asked for. Being talkative is never a good strategy during an audit.

DO - Prepare the Auditor

Being audited can be a stressful experience. However, you can ensure as-smooth-as-possible audit by properly preparing and planning for it. Have you ever taken an exam at the university when you didn't know anything, but for some reason, you still decided to give it a try? Now you are sweating in front of your professor because you don't know the answers and he sees the desperation in your eyes? Trust me, you do not want to be in this situation with the auditor - preparation is the key.

The auditor should be informed about what to expect during each interview with the site personnel, what needs to be reviewed with the coordinator, what topics should be covered, and the audit scope. Ideally, preparation should begin several weeks, even a month prior to the actual audit.

DON'T - Flood the Auditor with Documents

Provide the auditor with all the records, documentation, and any additional information they may request. Ideally, the auditor will not be allocated in the same room as the study folders and will ask you to bring him/her whatever is needed. However, avoid overwhelming the auditor with documentation that is not relevant to the audit process. Only provide the materials that will help the auditor better understand the site’s processes and the specific documents that are being requested.

DO - Ask for an Audit Plan Early

An audit plan helps both the auditee and the auditor to map out the audit effectively. It defines the audit work that will be completed and encompasses the overall strategy and detailed approach of the audit’s nature, timing, and scope.

Audit plans should be issued two weeks or so before the audit occurs to know the focus areas under review.

Moreover, your site team must be familiar with the audit plan to the point that they can clearly explain who is responsible for each task and understand the audit agenda step by step.

DON'T - Accept General Templates

If an audit plan can be used for multiple studies, then the auditor probably did not prepare using the pre-audit documents. Therefore, make sure that the template presented is customized to suit your operations.

General templates that do not reflect your site's (CRO) specific quality management system and processes will not add value to the audit process. A generalized template may also slow down an audit due to duplication and repetition. An ideal audit plan must demonstrate a good knowledge of your site processes and company SOPs.

DO - Stay with the Auditor

The CRA should accompany the auditor throughout the entire audit process (yes, even in the bathroom, if necessary). Active involvement is crucial at each stage of the audit to identify issues or areas of particular concern that should be addressed. Staying with the auditor also facilitates clarification of issues and asking of relevant questions. And God forbid, you leave your study documents unattended in the presence of the auditor. As a monitor, you should not in any circumstances, leave your auditor alone and wandering around.

DON'T - Wait to Ask Questions

Even if the auditor mentions a "wrap up" at the end of the day, don't wait until then to ask questions about their observations. Asking relevant questions lets you seek immediate clarification on areas that are not well understood or covered. This ensures that no issues remain unresolved and that there are no surprises at the conclusion of the audit. Asking questions may also resolve the majority of minor or even some major findings at the end of the day. So, do not be afraid to communicate, this may make the difference between a major or a minor finding.

DO - Take Notes!

During the audit process, take notes alongside the auditor on everything they do. This includes what has been reviewed, where they clicked in the EDC, and how many times they went back to check something for a patient. These notes may help determine if all audit objectives were met and if findings are substantiated. Additionally, CRA notes may cover something that the auditor missed during the closing meeting. They can also be used to argue against an unreasonable finding, if necessary. So, pay attention 😉.

DON'T - Dictate Notes

It should go without saying, but never dictate to the auditor what to write in their notes (please 🙏). Auditors should be free to write what they want and how they want. Dictating notes to the auditor is equivalent to influencing the outcome of the audit, which defeats the entire purpose of using an independent auditor.

DO - Challenge Invalid Non-conformity observations.

An audit seeks to verify that the practices being used conform to what is intended. However, there may be instances where the auditor makes invalid non-conformity observations. If you have reason to believe there is an invalid non-conformity, mention it. If the non-conformity is not a requirement, ask the auditor to make it a recommendation rather than noting a non-conformity.

Failure to challenge invalid non-conformities may result in difficulty identifying root causes and may result in inefficient allocation of resources.

DON'T - Confuse "Experience" with "Requirements"

Auditors may refer to "best practices" or "benchmark" approaches seen at other companies or sites. However, this does not always justify a non-conformity. For example, an auditor might ask to see notifications submitted to the Local Ethics Committee (LEC) because they saw these notifications in previous audits at other sites. However, if this is not a requirement of the regulations, as is the case for the LEC in Bulgaria, it should not be recorded as a non-conformity.

DO - Disseminate Audit Conclusions throughout the Company 

Every department manager should receive a copy of the audit report. This ensures that decision-makers have a clear picture of how the CRO/site is operating. An auditor's report points out inefficiencies and weaknesses in monitoring that may need to be addressed similarly in other parts of the company.

To ensure that the trials are conducted in full compliance, work with the your study lead/manager manager to create a CAPA for each nonconformity pointed out by the auditor.  This will help to track corrective actions to completion.

Another awesome practice that I appreciate being done at @PSI is the sharing of audit results and unusual findings among colleagues. We even hold regular discussions dedicated to discussing audit findings and how to improve our processes.

DON'T - Accept a "Perfect Score" 

Sometimes audits that result in no observations, recommendations, or non-conformities to report but this should not be interpreted as having a perfect system - an audit is just a collection of samples.  Rotating auditors is a good way to challenge (very gently) the quality management system with new perspectives. Every auditor looks at things differently.  A thorough audit process always points out areas that need improvements. It also provides essential recommendations on the way forward.

* That of course, if you a confident as heel, your audit went well. Otherwise, I definitely would not recommend getting too cocky.

A few more points came up in discussions with colleagues:

• In Bulgaria, a CRA shared that during an inspection by IAL (Bulgarian Drug Agency), the auditor took the site identification log and started calling patients to ask if they remembered participating in a clinical trial or when their last visit was. This is usually not a concern, but do keep in mind - we all know at least one site, which has more than 200 enrolled patients with a rare study indication in a remote area of the unknown Bulgarian northwest 😉.

• Another point that came up was the role of the site pharmacist, for sites that have an on-site pharmacy obviously. Again, the IAL inspector asked what precisely was the role of the pharmacist on site, since their signature was not present on any preparation/dispensation records. My colleague calmly explained that he cannot tell the PI who will do what in his own site team, and that the PI's signature was indeed present on all records. He ended up having a minor finding, and although the inspector agreed this is not against compliance, he simply did not like the fact that the site pharmacist was not involved in the study, while still being delegated.

And now you are ready (as ready as someone could be) to conquer your first audit with confidence!

While audits can be stressful regardless of how well prepared you are, it's important to keep calm, respond with professionalism, and stay open to feedback. After all, if you are 100% sure you have given it your best, there's no need to worry. In general, audits are a good thing as they ensure the quality of your work. In the worst case scenario, they can still be great learning experiences 😉.

When I think about it, all the major life lessons I learned were from my failures. Not that one cannot learn from positive experiences as well, but you know what they say - smart people learn from other people's mistakes, the stubborn ones learn from their own, and the stupid never learn.

When I had the idea for this article, I have to admit it mortified me. No one wants to have their mistakes and embarrassments published out there for everyone to see.

Each time I go on social media, I realize that everything on there is "fake" as all of us want to present ourselves in the best possible light for society to see. Our LinkedIn or Facebook profiles are not us - as much as we would like to identify with them. These are only the "polished" versions. But even knowing this, I still catch myself sometimes comparing myself to others whom I presume are "more successful than me" in some aspect. In those moments, I always try to remind myself that this is precisely what social media is designed for, but more importantly, I cannot see the bigger picture for this person - I do not know their struggles, their background, nor what they have been through to get where they are today. I do not know if they are happy or miserable, or whether this is the life they have chosen for themselves or if they are truly following the desire of their hearts. The truth is, you cannot compare where you do not compete.

“Seventy percent of young people experience Impostor Syndrome. Those who experience it are high achievers unable to internalize and accept their success. They often attribute their accomplishments to luck rather than ability, and fear that others will eventually unmask them as frauds. Millennials are particularly susceptible to Impostor Syndrome due to technological advancements within their lifetime, societal pressures, and social media comparisons.”

*you can read the full article here.

Studies also show that Imposter Syndrome affects more women than men, with around 40 % of young female professionals saying they feel intimidated by senior people, compared to just 22 % of males. The anxiety of being "exposed as a fraud" is extremely common among graduates, and the lack of experience is often the main culprit, especially for those moving into roles within highly competitive industries (such as clinical research). However, in order to gain experience, one must first get hired in the industry, which is not an easy task in itself. It is a "Catch-22".

Imposter Syndrome in clinical research is also a topic that deserves further exploration, but that's for another article (subscribe to my newsletter✌️).

Imagine you messed up big time. Now imagine the whole world knowing about it. Sucks, huh? But now - imagine reflecting on the situation and trying to see it from a different perspective - what went wrong? How could you have done better? And what could you do to avoid it next time?

In that train of thought, I decided to share some of (far from all) my failures through the years, both personal and professional, which helped me far more than I realized at the time to become a better expert in my field and a better human being in general.

My First Job as a CRA

Let me take you back to 2019. As my lifelong dream was to become a Clinical Research Associate (CRA), I lost count of the number of CRA job posts I applied to, but it was likely around 200. At the time, I was working full time as a clinical research expert with C3i (now HCL) while still at university. Although it was still related to the field, I was in a support role, dealing with the back end of the processes happening in the Clinical Trial Management Systems (CTMS) and communicating with sites, CRAs, and project managers. However, I did not want to pursue assistant roles which were generally easier to get hired on. I wanted to become a real CRA, so in my context, I was aiming for the stars. Despite my enthusiasm and passion for clinical trials, due to being in university and lacking previous CRA experience, no one wanted to hire me. I was prepared to face a lot of rejection, and I certainly did. Almost everyone that I've told about my desire to become a CRA, they just laughed and jokingly wished me good luck with it.

One day while walking my dogs, I received a call from a very nice lady inviting me to a CRA interview. It would be an understatement to say that I was ecstatic.

During the interview, my employer-to-be, asked me about my high school, as he happened to be a benefactor for the National High School of Science and Math, which I attended. I think I impressed him with that 😃. I also remember him asking whether I liked to drive. At the time, I had my driving license but had only driven occasionally as I did not have my own car. Nonetheless, I loved to drive, so I said yes. He hired me, and the following week I had my first monitoring visit. Needless to say, I had no idea what I was doing, but I tried to implement everything I had read the night before about routine monitoring visits, so I would at least look like a CRA.

At the end of the visit, I accidentally crashed his car on the hospital parking lot 🤦🏼‍♀️. I was sweating the entire way back to Sofia, trying to figure out how to explain what had happened. At one point, I thought he would fire me on the spot. He did not. That is another beauty of mistakes - usually, people are a lot more forgiving than you might think, provided that you have the courage to stand up and take accountability.

At least I knew how to write a monitoring report since I had managed the CTMS for plenty of studies in my previous role. However, I thought that ISF or TMF were plugs on my laptop (I know it is hard to believe after this comment, but I also worked as an internet engineer for Sky b.c. - before CRA). And don’t even get me started on MS Word. Back then, when reviewing a document, I thought “accept changes” meant sending back an email with the text “Dear….., I accept the changes in the document.” We had a few back-and-forths on this.

Of course, with time, I have learned a lot and become a much better monitor (duh, after all, when I started, I knew less than Jon Snow), my driving skills have also improved, as well as parallel parking. I believe it is safe to say that to this day, I keep learning new things about clinical trials, and I am constantly trying to improve my skills and knowledge. There is always room for improvement and this is one of my main drivers.

Communication with my sites

Throughout my career, I have experimented with different approaches in communicating with my sites. I have tried being extremely professional and keeping communication with the team strictly official. I have also tried being more friendly, hoping to build better trust with my sites. However, I have found that there is no perfect recipe for building a good relationship with your sites. It is more about adapting to the site team's communication patterns and letting them take the lead.

As an extremely extroverted and chatty person, it has always been challenging for me to maintain a strictly professional relationship with my investigators. It comes naturally to me to ask about their kids, invite them to lunch, or ask how their holidays were. However, I recognize that for many people, especially doctors, this would cross professional boundaries and would not be appropriate.

Over the years, I have had several instances where my friendliness has bit me on the butt. Recently, I had a co-monitoring visit at one of my sites with my study lead. This particular site had never had prior clinical research experience, and I saw it as a challenge to work with a complete "newbie" site to test my skills of teaching proper study execution. I taught them everything they now know about clinical research, from GCP to how to write patient source files. As a result, they are now one of my top-performing sites, and we have built good relationships with the PI and SI, to the point I now consider them part of my friend circle.

During the co-monitoring visit with my study lead, I had high expectations that he would leave the site with the impression of having seen the best-managed site in his life (I know, it sounds a little bit cocky), and that he would have no comments about the documentation. However, very predictably I must say, this was not how it went, and he did have several comments about things that I really wish I had seen beforehand. These were not major issues, but rather small details that I had overlooked. This caught me off-guard, as I was super confident in my abilities as an experienced CRA. To make matters worse, he also asked the PI and SI to leave the room while we were examining their files (at this point it was really more him reviewing my work), which only added to my anxiety. Later on, I realized that he did ask them to leave because he did not want to undermine my authority in front of the site team by discussing my mistakes in their presence. However, at the time, this seemed rude to me, as it was not my customary way of communicating with them.

All site issues are eventually fixable; however, this situation has damaged my relationship with the investigators. They no longer trust my judgment as they used to before and now request a second opinion from my lead all the time. They feel offended by the way we treated them during the visit. Needless to say, we are no longer on "friendly" terms. Despite this, our bottom line is to work together to get the job done, nothing more and nothing less. This was a lesson for me to learn: to keep a little bit of distance. At the end of the day, it is just work.

Dealing with superiors i.e., “difficult” managers

Phew, this is a tough one. I have to admit that throughout my modest career, I have almost never faced a challenge with "difficult" managers. It's quite the opposite-almost all of my managers have been amazing professionals and mentors whom I look up to.

However, the situation with a difficult manager is painfully familiar to many people, and it is usually the original cause of CRA burnout, switching companies, and in some cases, even careers. Remember, people never really leave certain positions but rather toxic work environments. For the most part, it is up to the managers to create a positive work environment.

I have been in situations where, at some point, I felt extremely frustrated, overburdened, and mostly unheard by my manager. I'd like to add to this part that communication with other people is often the most challenging part of the job, regardless of the field. This could happen in both online or face-to-face communication (there are things that could be left unintelligible in both types) and could leave the other person with a bitter feeling after the conversation, simply because you did not express yourself properly, or the other party understood something completely different. In many cases, you could just be lost in translation. Or in rare occasions, the manager could simply be an arse 🤷‍♀️.

Personally, I have a straightforward approach to things. If I dislike something, I bring it up, discuss it, come up with an action plan, and try to resolve it. However, this approach may be outside the comfort zone for many people, who may instead engage in what is called "quiet quitting."

*To learn more about "quiet quitting," click here.

There is no playbook for dealing with situations like this, but from my experience, I can give you a few hints:

• Don't take it personally. It's rarely personal. Usually, it has something to do with work overload or the other person's character, rather than you.

• If you decide to address the elephant in the room, speak directly with the manager in question. This will save a lot of wasted time and energy and will leave no room for interpretation from your colleagues. You don't want to get into the game of he said, she said.

• Express your frustration towards the situation, NOT towards the person. This is a hard one, I admit, but what I try to do is very carefully pick my words (it helps if you come prepared for the meeting - write down everything you wish to address) and figure out a way to talk about the particular situation/issue, rather than focusing on how this made you feel. If you fail to do so, things can get personal very easily, and it's a rabbit hole from there, trust me. Also, try to have such conversations on Friday, as this will give all parties time to calm down, think things through over the weekend, and start the next week with a fresh perspective 😉.

Audit: my first major finding

Rather soon after becoming a CRA, I received an email that can induce fear even in the most fearless CRAs out there.It was notification that I was about to undergo my first audit. The study had already completed the enrollment period long before I became a CRA. Additionally, there were no active patients at the site, and I had never met the site team. Nonetheless, the audit was only a week away.

The next day, I called the site to arrange my first routine visit, only to discover that the principal investigator (PI) did not speak English and had only a vague recollection of the protocol specifics. Additionally, the on-site files were almost non-existent, and we lacked patient source files (or at least we lacked them in a format, in which they could be presented to the auditor) for approximately two-thirds of the patients.

Now, the normal reaction to this would be any of the following: inform my superiors, try and re-schedule the audit; ASK FOR HELP; any of the above would do. What did I do? In the spirit of being a young and ambitious CRA, I have decided “challenge accepted!” and dove headfirst into the pit of my downfall.

I spent the entire following week on site, working from dawn until dusk. During this time, I taught the PI the protocol, good clinical practice, basic English skills, and more. In addition, I assisted the SI in preparing proper source files for most of the subjects. During my spare time (on the weekend), I worked on the OSF. I must note, however, that at that time, the OSF was still a bit of a mystery to me, therefore, I hardly did the best job possible. At certain points, I only left the site to walk my dog at around 9 PM so that I could come back and wrap up for a couple more hours.

Monday arrived, and with it came the Swiss auditor. I arrived at the site at 7:20 AM and looked through the window to see the auditor already in the PI's office having coffee and chatting. My heart sank; this could not be good.

I entered the room, introduced myself, and attempted to engage in positive small talk to build rapport with the auditor. However, my tendency toward over-friendliness (yet again) and talking too much did not work this time, as the guy was Swiss. To my surprise, apparently the English lessons I have been giving the PI paid off. He found himself blurting out far more details than necessary, which would have been better left unsaid (unless specifically asked for).

At this point, you're probably already guessing, but the audit went dreadfully. Two days of misery ended with my first major finding. There were also some minor findings, but I remember feeling relieved at the end of the audit, because I thought it could have been much worse 🫥.

On top of that, I had to explain to my manager why we were in the situation we were in, and NOW I had to ask for help to fix all the CAPA actions. It took me six months of hard work with the site and a significant amount of damaged ego to fix what I had messed up. I wish I could say that I learned from this situation to ask for help when I need it instead of thinking I can do everything on my own, but it took me several more failures to realize what it means to be part of a team and that help will always be given to those who ask (I stole the last line from Prof. Dumbledore 🧙‍♂️).

The silver lining

I wrote this article with brutal (95%) honesty - as Tars says in Interstellar: "Absolute honesty isn't always the most diplomatic nor the safest form of communication with emotional beings." I figured the same applies to the pharma industry.

I am sharing all of this with the sole desire to keep things real, especially in a world where we are constantly surrounded by the illusion of "perfection." I firmly believe that growth happens precisely from our biggest mistakes, as long as we are able to learn from them and strive to do better next time. For me, sharing my most uncomfortable experiences also helps me gain clarity on where things went wrong and how I can improve for future reference. Of course, that doesn't mean I won't make mistakes in the future, but I like to think they will be a different set of mistakes. And honestly, I can't wait! I hope you have also learned something from mine ✌️.

Disclaimer: although I have never been a big fan of astrology due to my firm belief that it is not a real science, I find it to be an amusing and even entertaining topic. In fact, this has even led me to come up with a fun idea to represent the different types of CRAs, as per their zodiac signs.

With my (admittedly limited) knowledge of astrology, I delved into the intricacies of each zodiac sign to create unique personas for each type of CRA. The end result is a list of the twelve CRA zodiac types.

And so, with that being said, consider this as your small guide the next time you are asked the question, "Oh, but of course, you chose this career. You are a Capricorn, right?”

1. Aries (March 21 - April 19): The Energetic CRA Ram - Always on the go, full of enthusiasm, and ready to tackle any challenge that comes their way. Known for their dynamic and assertive nature, they charge ahead in monitoring clinical trials with unwavering determination.

2. Taurus (April 20 - May 20): The Reliable CRA Bull - Known for their steady and dependable nature, they meticulously review study documents, ensuring accuracy and compliance. They have a keen eye for detail and are committed to maintaining high standards in clinical trial management.

3. Gemini (Me, myself and I 👩🏼‍💻) (May 21 - June 20): The Versatile CRA Twins - Adaptable and versatile, they excel (hehe pun intended 😃) in multitasking, effortlessly managing multiple study sites and tasks simultaneously. With excellent communication skills, they build rapport with investigators, sponsors, and study teams with ease.

4. Cancer (June 21 - July 22): The Compassionate CRA Crab - Known for their caring and empathetic nature, they prioritize patient safety and well-being above all else. They go the extra mile to ensure that patients in clinical trials receive the best possible care.

5. Leo (July 23 - August 22): The Confident CRA Lion - Bold and confident, they take charge of clinical trial monitoring with a commanding presence. They are natural leaders, inspiring and motivating study teams to perform at their best.

6. Virgo (August 23 - September 22): The Meticulous CRA Perfectionist - Known for their attention to detail and methodical approach, they leave no stone unturned in ensuring that clinical trials are conducted with precision and accuracy. They thrive in maintaining meticulous records and documentation.

7. Libra (September 23 - October 22): The Diplomatic CRA Scales - Known for their fairness and balanced approach, they excel in resolving conflicts and maintaining harmonious relationships among stakeholders in clinical trials. They ensure that all parties are heard and work towards finding mutually beneficial solutions.

8. Scorpio (October 23 - November 21): The Intuitive CRA Scorpion - With keen intuition and perceptive skills, they are adept at identifying potential issues in clinical trials and taking proactive measures to mitigate risks. They are tenacious and resolute in ensuring that trials are conducted smoothly.

9. Sagittarius (November 22 - December 21): The Adventurous CRA Archer - Known for their adventurous spirit, they are always eager to explore new territories in clinical research. They embrace challenges and are constantly seeking innovative approaches to improve trial processes.

10. Capricorn (December 22 - January 19): The Ambitious CRA Goat - With a strong drive for success, they are focused and goal-oriented, striving for excellence in every aspect of clinical trial management. They are known for their professionalism and determination to achieve results.

11. Aquarius (January 20 - February 18): The Innovative CRA Water Bearer - With a progressive mindset, they are always seeking new ways to improve clinical research processes. They are known for their creativity and out-of-the-box thinking in managing trials.

12. Pisces (February 19 - March 20): The Compassionate CRA Fish - With a compassionate and empathetic nature, they prioritize patient-centricity in clinical trials. They are known for their ability to connect with patients and provide support, making them invaluable in patient-centric research.

Remember, these associations were made purely for fun and should not be taken seriously. Zodiac signs have no scientific basis and do not influence an individual's career choices or professional abilities.

The role of a clinical research associate (CRA) is determined by our education, experience, skills, and qualifications, rather than the zodiac sign. Withe that being said, keep in mind when choosing a career or making professional decisions, it's always best to rely on evidence-based information and personal interests, rather than astrology.

And if you’d like to learn more about how you can pursue a career as a CRA yourself, you can check out one of my other (definitely brighter) articles: How to become a CRA for dummies in 7 steps (or less).

And which CRA-zodiac are you? Do you find the astrology to be true for you? Let me know in the comments below!

The CRAs get to travel to fancy places

Let's start with the obvious - CRAs travel a lot. As I mentioned in my previous articles, most companies require around 8 days on site per month (not including travel to and from sites, which should also be considered depending on the distance or your mean of transportation).

However, as a CRA, especially at the beginning of your career, it's rare to have the opportunity to select your own site locations or even choose sites from a list. Most likely, you'll be assigned somewhere in Bulgaria, and chances are it ain’t gonna be glamorous.

Site locations depend on study indications and where the best PIs that you will be working with are. When I started monitoring, my first sites were in Sofia (the capital), Plovdiv, Ruse, and Kozloduy. I had a normal amount of visits per month, nothing excessive, but it still required a lot of travel. Considering that I'm a very active person with a routine for workouts, a strict eating regime (or at least it used to be strict, as I was trying to and eventually did lose 13 kg), and a dog, I had to adapt to incorporate my lifestyle with the responsibilities of being a CRA and spending a lot of time on the road. I had to figure out where I could eat healthily, work out, walk my dog, or meet friends while away from home.

As your career progresses, you may gain some flexibility depending on your location preferences and, of course, your employer.

In 2019, I frequently visited Kozloduy, a very remote small town. At some point, I began spending at least one to two full weeks per month there, so I started bringing my dog with me. Here, he actively helps me monitor patient questionnaires.

During our morning walk in the city, Ari and I visited an important historical landmark: the Radetzky ship. It is now permanently located on the Danube riverbank near Kozloduy. Walk for Ari, 8 km run for me 😰 Bonus points if you manage to outrun the mosquitoes!

With that being said, I absolutely love traveling and exploring new cities. I have always managed to combine my lifestyle and activities with my job. I have seen some awesome, even if not-so-fancy places, such as the sunset over the Danube on the Ruse riverbank, the old town in Plovdiv, and even the winter in the Vrachanski Balkan. All of these places have their own charm, but they certainly do not qualify as your typical “glam destination”.

I love the sunset over the Danube River in Ruse. This city holds a special place in my heart, because I used to spend my summer vacations there as a kid, with my grandparents.

If you're wondering, this is what an awesome visibility day looks like in the mountains near Montana and Petrohan. If you're assigned to sites in this area, I'd recommend investing in some high-quality winter tires to make sure you're prepared for anything!

The CRAs make a lot of money

Well, this is not a myth! 😜

To be fair, I realize that this is a very sensitive topic, and I even contemplated whether I should include it at all. But the reality is that everyone works for money, no matter how much they love their job, and I am no exception. CRAs do make enough to live a very good, even privileged life (by Bulgarian or worldwide standards), and I would be lying if I said that this didn't influence my decision to choose this career path. As a clinical research associate, you can expect a highly competitive salary ranging from 70k to 120k annually, depending on your level of degree, experience, the company you work for, and the number of site visits per month.

Many companies also offer yearly and performance-based bonuses, as well as car and meal allowances, full health insurance, Mulisport, and team building activities. Some larger CROs also offer a sign-in bonus.

Taking all of this into consideration, being a clinical research associate is a very sweet job. However, you cannot expect to retire in your 30s and take a sabbatical. You will earn enough to have a comfortable and worry-free life, and you will be able to provide for yourself and your family as long as you work and have a savings plan. But do not expect to live a millionaire lifestyle, buy a private jet, or live in a mansion on the French Riviera.

The CRAs have the luxury of making their own schedule

Compared to other positions in clinical research or other jobs in general, CRAs have a more flexible schedule. With proper planning and time management, you can arrange your schedule to fit your needs while still complying with the monitoring plan for your studies, site requirements, and upcoming DMCs.

However, keep in mind that with freedom comes responsibilities as well. You may have arranged your schedule for the month or the next three months, but you could receive a Sponsor request for an emergency visit, re-SDV, additional review of safety data, or some sort of integration between EDC and the central lab, SAE, or audit notifications. These requests may not fit neatly into your schedule, but you will be expected to promptly react and perform the required visits or tasks, regardless of how many hours it will take.

Nevertheless, in my opinion, this is a fair price to pay considering that, for the most part, you have the freedom to work remotely and manage your activities to suit your schedule. Also, I have some excellent podcast recommendations for long drives across the country. 😜

CRAs only perform administrative tasks

Surprisingly, it's a common myth that portrays CRAs as individuals who only perform administrative tasks, such as filing paperwork, coordinating meetings, and reviewing documentation. However, my friends, this doesn't come close to describing what we do (it's called the CRA wizard for a reason 🧙‍♂️).

CRAs are highly skilled professionals who play a crucial role in managing and monitoring clinical trials. We're responsible for ensuring that clinical trials are conducted in compliance with relevant regulations, protocols, and standard operating procedures (SOPs), monitoring patient safety, and collecting accurate data. We must stay up-to-date with ever-changing information on a yearly, monthly, or even weekly basis. We're the first point of contact for our investigators, project managers, project assistants, vendors, and sometimes even the hospital's accountant or lawyer. Our skill set includes everything from managing clinical trials and critical thinking to working well under pressure, coming up with fast solutions, and working extensive hours while still looking presentable at the job.

• I have jumped fences (literally) to deliver site lab supply kits. On one occasion recently, while in the process, I almost received a parking ticket while hanging from the fence in question. I had to explain to the police that I am a respected expert in my field and that I was just doing my job.

• I have physically moved such amount of OSFs, that I could probably qualify for heavy lifting competition.

• I have driven through mountains and rivers (again, literally), through storms day and night, and through remote and off-road areas (long live the Tucson) to reach clinical sites or hotels in the middle of nowhere. Once, I saw a llama (which is definitely not a typical animal you see every day in Bulgaria) tied to the front door of a hotel where I was staying.

• Once, I had the opportunity to witness a TURBT procedure (if you're curious, you can google it) being performed on a patient from the front row, right behind the PI's shoulder. Fortunately, the patient was not one of the subjects in my study. Despite my initial apprehension, the procedure turned out to be quite fascinating.

CRAs don't have a significant role in patient care

I'd like to address another myth about Clinical Research Associates: that we are not involved in patient care. However, as I mentioned earlier, CRAs are responsible for monitoring the safety and well-being of patients enrolled in clinical trials.

I often hear people say things like, "Yeah, but you're not actually involved in the research itself," or "The Pharma industry is evil anyway, you're working for the bad guys," or "You guys don't even care about the patients, it's all about profit." But let me be clear: CRAs ensure that patients are receiving appropriate medical care, review medical records and charts, and assess adverse events or side effects related to the investigational drug or device being studied. CRAs play a critical role in safeguarding the health, rights, and welfare of patients participating in clinical trials.

We CRAs get extremely excited when a drug that we have worked on for a long time receives approval, or when an investigator shares results showing that a patient has no sign of tumour progression or recurrence, or whenever someone's life is changed for the better. These things make all the paperwork and monitoring tasks worth the time invested. And it feels great to be a part of all of it!

CRAs are not required to have a strong scientific background

One of the biggest misconceptions about Clinical Research Associates is that they do not require a strong scientific background. Actually, I am often being asked “Why did you study pharmacy if you were going to work as a CRA anyways? I know people with degree in arts, who are doing it!”

However, in reality, CRAs are typically required to have a solid scientific foundation and understanding of clinical research principles, regulations, and guidelines.

Usually CRAs are required to have background in medicine, nursing, pharmacy, life sciences, or other related fields. Moreover, we often undergo extensive training and certification programs to develop our expertise.

While it is not impossible to enter the industry with a degree in finance or psychology and then gain some medical knowledge on the job it will certainly be more challenging. The majority of people working in the industry do have a medical degree - this includes your colleagues, hiring managers and the primary investigators (PIs) at the clinical sites. Therefore, having some sort of medical background will give you a better reputation and frankly, will make your job a lot easier.

In addition, being a CRA requires a degree of medical and pharmaceutical knowledge. You will need to participate in medical discussions with investigators, monitor a lot of safety data (including adverse events and patients' treatment), and have a basic understanding of each therapeutic area you're working in. In my opinion, considering all of the factors, a medical background is a must for the position. Remember, a CRA is not an entry-level position.

It's important to recognize that CRAs play a critical role in the conduct of clinical trials and contribute significantly to the advancement of medical knowledge and patient care. My ambition is, that dispelling these myths can help provide a more accurate understanding of the important work that CRAs do in the field of clinical research.

And speaking of misconceptions, have you heard any about clinical research associates or site investigators? I'd love to hear from you in the comments or via message.

Peace out! ✌️

Back in the day, many of my fellow colleagues from the Medical University asked me about becoming a CRA, mostly while we were still in our final year (which was when I became a CRA). But this is still a hot topic even today, especially when I speak with other people from the clinical research space who are currently in different positions but would like to progress to a CRA position.

In this article, I will share the steps I took to land my first CRA interview, along with some lessons I learned along the way.

Gain industry knowledge

Let's begin by acquiring knowledge of the industry. Regardless of whether you are currently in the clinical research space or not, it is important to know as many details as possible about the type of job that CRAs do. This means that you will have to invest a significant amount of time in research. What is a CRO? Who is the "Sponsor"? What is the difference between being a CRA for the Sponsor or the CRO? What other departments are there (e.g. start-up, pharmacovigilance, regulatory, legal, etc.) and who is responsible for what? What does the job of the CRA consist of, and what are your daily responsibilities? Also, try to learn the industry lingo. What is the TMF, ICF, and ISF (yes, those stand for very different things), what is the IB, and what information can you find there? What are the different types of visits, and how often are the DSURs submitted?

All of these questions and topics will be discussed during your CRA interview.

With that being said, it is unlikely that you will be given a test to complete during the interview in an exam-like setting. However, these topics are important and will most likely come up, so it is better to be prepared and know what the conversation is about. It is almost guaranteed that, even if you have clearly stated that you have no previous monitoring experience, you are being interviewed for a CRA role (which is not an entry-level role in any case). Therefore, it only makes sense to be at least a little bit familiar with the space.

I am also planning to write a dedicated article about the five types of entry-level positions in the clinical research field that do not require experience, but could serve as a stepping stone to your career as a CRA. If you would like to receive a notification about it, please subscribe to my blog.

You can acquire knowledge about the industry by using the brilliant invention called Google. Even better, these days we have the option to ask ChatGPT any question that pops into our head. Just make sure to fact-check the provided answers.

You can also find several clinical research "influencers" online who talk about many topics in the research field. They can provide a lot of insights and specific examples that will aid you in your exploration.

Lastly, look around. There must be someone around you in your circle, who is already in the industry and whom you can ask everything there is to know in order to land your first CRA interview.

This brings me to my next precious advice:

Networking

I cannot stress enough how important it is, especially at the beginning of your career, to have a wide network of contacts and people who are willing to help you. This is particularly crucial when you need all the connections and help you can get, especially at the beginning of your career.

Many of the young people I talk to, including my mentees, tend to underestimate the importance of having a broad network of contacts who know and are willing to assist them on their road to success. Think about it: people in the industry know each other and are more likely to refer someone whom they know and have a high opinion of. That is why you need to know these people. If you are well-connected, you will have significantly better access to information about the clinical research world, job opportunities, news, accreditations, and even recruiters.

The harder question is: How can you create your own network?

LinkedIn

The simplest possible way is to use social media to your advantage. In this case, I suggest using LinkedIn.

LinkedIn is a great platform that connects people. The algorithm is simple yet efficient, and all you need to do is understand how it works. Here are a few examples:

Set up your profile right!

First things first - you will need a kick ass profile! That means you will need a good professional profile picture (please refrain form uploading bikini pics, or selfies in front of your BMW form 2005 - this is not the right platform for such content and frankly probably no one wants to see them in any occasion).

Choosing the right profile picture for your LinkedIn profile is crucial, as it is often the first impression potential employers, clients, and colleagues will have of you. Here are some basic tips to help you choose the best LinkedIn profile picture:

1. Professionalism: Your LinkedIn profile picture should be professional, and should align with the image you want to portray in a professional setting. Avoid using casual or overly informal photos, and choose an image that reflects your industry or the type of work you do.

2. Quality: Your profile picture should be clear and of high quality. Avoid blurry or pixelated images, as they can make you appear unprofessional. Use a high-resolution photo that clearly shows your face and features.

3. Approachability: Choose a photo that makes you look approachable and friendly. Smile naturally, and make sure your facial expression is warm and inviting. Avoid photos with a serious or stern expression, as it can create a negative impression.

4. Professional Attire: Dress appropriately for your industry. Wear professional attire that is suitable for the Pharma field, and avoid clothing that is overly casual or distracting. Dress as you would when attending a professional event.

5. Background: The background of your profile picture should be simple and uncluttered, and should not distract from your face. Avoid using busy or distracting backgrounds, and opt for a clean and neutral background that keeps the focus on you.

*The same strategy applies for your LinedIn cover as well - the main focus should always be on you. And no, not having a background is not an option, you will be looking like a bot.

1. Authenticity: Choose a photo that represents you authentically. Avoid using heavily filtered or overly edited images that do not accurately represent your appearance. Be genuine in your profile picture to build trust and credibility with your LinkedIn connections.

2. Consistency: If you use a profile picture across multiple professional platforms, such as LinkedIn, your website, and other social media profiles, consider using a consistent image to create a cohesive online presence. This can help you build brand recognition and create a professional image.

3. Professional Headshot: this might be a little extensive, but you want to consider getting a professional headshot taken by a photographer who specializes in professional portraits. A high-quality headshot can make a significant difference in how you are perceived on LinkedIn and ultimately could be the “make it or break it” when recruiters are choosing between you and another candidate for an interview.

Remember, your LinkedIn profile picture is an important part of your professional online presence, and it's worth investing time and effort into choosing the right one. Use the tips above and select a profile picture that presents you in the best light and aligns with your professional brand.

Another thing is your professional experiences. I‘d suggest if you do not have any, list only your degree, along with a relevant course or certificate you have completed. For example, courses in design of clinical trials, project management, or risk-based monitoring would be relevant. I am saying relevant, because no amount of certifications in numerology or human design will get you any closer to that CRA (or any other) interview.

Furthermore, if you have any volunteering experience (e.g Mentor The Young), this is a good place to mention it as well.

Meet the industry

Now that you've glammed up your profile, it's time to start connecting with people.

When I was searching for a CRA position, I followed a simple rule: connect with people in the same position, that you would like to be on, or similar positions. For example, before I became a CRA, I searched for people in each pharmaceutical company or CRO and added every single CRA, Senior CRA, Clinical Trial Manager, Hiring Manager (these are actually people of high interest), Project Managers, etc. Once their connections saw that they knew me, they started connecting with me too, because I was part of their generic professional field and LinkedIn would suggest me as someone they knew. This is what I meant when I mentioned being aware of how the algorithm works.

This will lead to a lot more opportunities. You can directly contact people who are of interest to you. For example, you could politely introduce yourself, explain your goals in the industry, and ask for tips or if they know someone who is hiring and to whom they could introduce you. This will ultimately help you on your way to your first CRA interview.

Attending networking events is a great way to meet people in our field. Unfortunately, this practice is not yet very popular in Bulgaria, but you can always check the calendar for interesting Pharma events. One good example is the Forbes Healthcare Summit.

I would also like to introduce a series of networking events for clinical research professionals in Bulgaria that I am launching together with Maya Zlatanova - Trials Together: Clinical Research Professionals Networking.

These events aim to help people in the clinical research space to start meeting regularly, exchange experiences, and mingle with other research experts in our field. I am very excited because there isn't anything like this in Bulgaria yet, and I believe it will provide great personal and career opportunities for all of us in the long run.

Networking events are a great way to meet potential employers and leave a lasting impression. You have the opportunity to showcase your skills, knowledge, and passion for the job, allowing the person you meet to better understand you and potentially want you to work on their team. This sets you apart from other candidates, who are just another piece of paper in a stack of resumes. It's much easier to make a good impression in person than on paper.

Prepare for the actual interview

This may seem like a no-brainer, however, I am always surprised by the number of people who put so much effort into landing their dream job interview, yet don't actually prepare for it and ultimately blow it off.

With that being said, here are some tips for a great first interview, regardless of it is in person or online:

1. Research the Company: Thoroughly research the company you're interviewing with. Familiarize yourself with their mission, values, products or services, organizational structure, recent news, and any other relevant information. This will help you tailor your responses during the interview and demonstrate your genuine interest in the company.

2. Review the Job Description (if you haven’t already): Carefully review the job description and make note of the key skills, qualifications, and responsibilities required for the CRA position. Be prepared to speak to how your skills and experience align with the job requirements.

3. Practice answering common interview questions, such as "Tell me about yourself," "Why are you interested in this role?", "What are your strengths and weaknesses?", and "Tell me about a challenge you faced and how you resolved it." Rehearse your responses in a clear, concise, and confident manner. I suggest trying this in front of a mirror or recording yourself to improve your public speaking skills and identify areas to work on. Additionally, set a time limit and stay on topic to avoid lengthy and uninteresting explanations that shift the focus away from the question.

4. Prepare Questions to Ask: Prepare thoughtful questions to ask the interviewer. This shows your genuine interest in the role and the company, and also gives you an opportunity to gather more information about the position and the company culture. Avoid asking questions that can easily be answered through basic research. Also, it may be obvious, but do not ask for the salary right away. If it is absolutely necessary, never use a precise number, but instead provide a salary range.

5. Dress Professionally: Dress professionally for the interview, adhering to the company's dress code or industry norms. Dressing appropriately shows respect for the interview process and conveys a professional image.

6. Prepare for Behavioural Interviews: Many interviews now include behavioural questions that assess how you've handled past situations. Use the STAR method (Situation, Task, Action, Result) to structure your responses and provide specific examples of your achievements and problem-solving skills.

7. Practice Non-Verbal Communication: Remember that non-verbal communication matters, too. Practice maintaining eye contact, smiling, and using confident body language during the interview. This can convey confidence and professionalism.

8. Research the Interviewer: If possible, research the interviewer(s) and their background. This can help you establish rapport during the interview and tailor your responses accordingly. Try connecting them on LinkedIn, in case they are not already in your network of connections, as they should be.

9. Think about all possible scenarios that you could be asked about - Usually, all CRA interviews involve scenario questions, such as: How do you prepare for a routine visit? What would you do if you have a non-responding site/PI? What would you do if you discovered missing source documents just prior to an on-site audit? These questions help the interviewer evaluate your problem-solving skills, critical thinking, and experience. Therefore, they are of crucial importance. You can figure out how to answer them by doing your own research on the topic or asking a more experienced fellow CRA 😉

10. Follow-Up: Don't forget to send a thank-you email or note after the interview, expressing your appreciation for the opportunity and reiterating your interest in the position. This is a really nice gesture that shows you value the time of others and, once again, sets you apart from most candidates.

Thoroughly preparing for an interview can demonstrate your qualifications, show your genuine interest in the position, and increase your chances of success. I believe that if you are able to land a CRA interview, you should be able to sell yourself well enough. Invest time in polishing your presentation skills, as they will come in handy in many work and life situations.

Try again

Overall, none of these steps are extremely difficult, and most of what I have told you is more or less common sense when searching for a CRA job. What makes a difference is dedication, invested time and effort, and consistency.

On your journey, you will face plenty of rejections. Plenty! In most cases, there is nothing personal behind it; there was just someone better than you for the position. This should not discourage you in any way, as long as you invest enough time and effort. Eventually, you will be able to get your dream job. The trick is to be persistent and constantly look for ways to improve yourself and learn from past mistakes. I know it all sounds scary and complicated, but "just keep swimming!"

Remember, it only has to work once!

As mentioned in my first article, How to become a CRA for dummies in 7 steps (or less), the Clinical Research Associate (CRA) acts as a liaison between a sponsor company (e.g., the pharmaceutical company paying for the study's execution, usually a patent holder) and the clinical research sites (i.e., the medical facilities where the investigators administer the investigational medical product to patients).

As a clinical research associate (CRA), your day-to-day activities can vary significantly. depending on the phase of the clinical trial and the project-specific tasks assigned to you.

Nonetheless, there are some general tasks that are part of every CRA's job characteristics, and I will go through each one of them.

Site Visits

A significant aspect of a CRA's job is to conduct site visits, ensuring that the study is conducted according to the protocol, ICH-GCP guidelines, and regulatory requirements. Typically, you would follow a monitoring plan that provides the timeframes for on-site visits. The frequency of this visit will also depend on the enrolment rates of your assigned sites. During these visits, the CRA reviews study records, medical records, patients' source documents, and case report forms, while verifying that the informed consent process was properly conducted. The CRA also observes study procedures, monitors adverse events/serious adverse events, performs accountability of the IMP (investigational medicinal product, aka the study drug), and reviews/updates the study on-site file (or "your folders down there," as one of my PIs refers to it) or any other site activity required to be done at the site.

Once I was called on site, because the SC had a panic attack, since in the protocol requirements for this particular visit, a faecal specimen was required to be collected form the subject and the subject was in no position to provide anything for collection. The SC kept the subject in almost a hostage-like situation with the hope that she would get what she needed. Eventually she dismissed the poor patient to go home and I have recorded a minor protocol deviation. Needless to mention, the study coordinator was a newbie.

It is important to mention that there will be sites with which you will have a great relationship with, and visits will be pleasant, enjoyable, and productive. The team will perform their job well, with extreme discipline and attention to detail, and the entire study will generally go smoothly.

However, be prepared for the fact that not all investigators are easy to communicate with. Some may be tired, busy, grumpy, or overloaded with work, and the CRA visit may be the last thing on their mind. Some PIs may be quite tough to work with, but unfortunately, not speaking with them is not an option, as you need to get your job done. I will review these types of investigators/situations in detail and explain how to handle them in another article. I’m just going to mention here that it's important to keep in mind, that first impressions are crucial. It's your responsibility to present yourself in the best possible way, as this will be the foundation of your future relationship with the site.

In terms of types of site visits that you will most likely conduct, here are some examples:

Feasibility, Site selection or Site qualification visits

Feasibility or pre-study visits are conducted to identify potential sites. The goal is to meet with the potential principal investigator and study team to confirm their readiness to take on the trial, and most importantly, to ensure that they have a sufficient patient pool for the respective study indication.

In some (larger) companies, the start-up team is conducting these visits and the study is being handed over to the CRA just prior the site initiation visit.

Site Initiation

Site Initiation Visits (SIVs) occur once the site has been selected, the study has been approved, all CTAs executed, and of course, the PI knows his Rave password (that is the ideal scenario, in most cases he would have missed the registration email).

SIVs are usually tough, demanding, and time-consuming as you will need to train your site on the protocol, vendor systems, labs, safety, study drug handling and all there is to know for proper study conduct. Needless to say, it is highly recommended to have red the study protocol prior to the visit.

Routine Monitoring Visit

Here's where monitoring really shines. These are the most common visits that a CRA will conduct throughout the study's duration. They involve a significant amount of source data verification (SDV), review of informed consent forms (ICF), and verification of eligibility. During these visits, your job is to closely monitor patient safety and any protocol deviations. If you don't have bloodshot eyes by the end of the day, you're not doing it right.

Site Close Out Visit

I had a colleague whose mantra for close-out visits was "Throw the ISF (investigator site file) on-site and run." In many cases, the process may not be that simple. Here you have reached the point where everything needs to be wrapped up: all documentation must be perfect, all action items completed, all logs have to be signed and all IPM/study equipment returned.

Motivational Visit

This visit is usually performed for slow-enrolling sites that are having trouble with recruitment. These sites may not be able to reach their preset enrolment targets, may not have enrolled a patient in the last year, or may simply lack motivation to work on the study. Ideally, you would want to identify the exact pain point that led to this visit initially.

Sponsor on site/Audit

These are, fortunately, not that frequent. You probably would get 2-3 of these per year. However, when they happen, you will suddenly become religious.

If you are interested in further details on how to prepare and what to do on each visit, subscribe to my newsletter. I plan to write a separate article dedicated to that.

Planning and Preparation

Reading emails should be your first activity in the morning while sipping on your coffee. Hopefully, there are no SAE alerts at your sites. When not visiting sites, you will spend the majority of your time replying to emails, preparing and reviewing trackers, following up on site issues and action items, reviewing protocol deviations, and working closely with the whole project team to ensure your study is going smoothly in all aspects.

All of this is required for you to be well-prepared for your next on-site visit. You usually want to have a great overview of all that has been done and what needs to be done.

Monitoring and Reporting

The CRA is responsible for ensuring the accuracy and completeness of study data. They review data listings, identify discrepancies, and work with site staff to resolve any issues. After each on-site visit, the CRA prepares a detailed report and sends it to the sponsor. This report provides an overview of the study, including any issues at the site and updates on study progress. It's crucial not to hide any issues from the sponsor, even with good intentions, because they will eventually come out. Failure to report an issue could and most probably will lead to blame being placed on you.

Administrative Tasks

These tasks could include managing study supplies and equipment, maintaining study documentation, filing paperwork, and preparing for audits or inspections.

Training and Development

As a CRA, it is crucial to stay up to date with industry regulations, guidelines, and new technology and innovations in Pharma. Attending training sessions, seminars, and conferences can be a great way to enhance your knowledge and skills, and more importantly, to broaden your network of contacts in the healthcare space. These events can also be enjoyable, as they often include networking opportunities and fancy cocktails.

Is it for you?

Overall, the CRA job is extremely exciting, dynamic, never-ending, and full of dynamics. I guarantee that you won't get bored. Just make sure to come ready and prepared to take up on a challenge 😉 Most importantly, it is extremely fulfilling and creates a good feeling in your soul, as you are a small part of something huge, that, one day, will make someone's life better.

As a result, I am frequently asked by people around the world about how I became a Clinical Research Associate (CRA), how I started my career in clinical research, and how to get noticed by a Contract Research Organization (CRO) or pharmaceutical company. In this article, I will share my experience and insights with the hope that many of you will find it useful and learn from my mistakes.

Formal Education

Let's begin with the first step: obtaining the right education for the job. This typically involves a degree in medicine, pharmacy, or a related field with a strong scientific background. While it is not impossible to enter the industry with a degree in finance or psychology, it will certainly be more challenging. The majority of people working in the industry have a medical degree - this includes your colleagues, hiring managers (especially in larger or better companies), and the primary investigators (PIs) at the clinical sites. Therefore, having a medical degree will give you a better reputation and make a better first impression. Not to mention that being a CRA requires some degree of medical and pharmaceutical knowledge. You'll need to participate in medical discussions with investigators, monitor a lot of safety data (including adverse events and patients' treatment), and have a basic understanding of each therapeutic area you're working in.

Experience

Experience is the harder part. At the beginning of my career, I faced a lot of rejection. I was already in my final year of medical university, but I had no experience as a clinical research associate. Every single CRA position I applied for required some experience. However, there is a workaround. You could still land your first CRA interview and job offer by working on different, less "fancy" positions still within clinical research, such as study coordinator at a clinical site, project assistant at a CRO, junior CRA/internships, or in my case, clinical application specialist for a couple of years. The idea is to gain as much experience as possible, be extremely proactive, and be willing to invest in your career long-term. At the beginning, your salary might not be high, and your job might not be that interesting, but you need to invest in this to gain enough knowledge and experience to land a CRA position. Even if you have to suck it up for six months to a year, it is worth the investment.

Another tip is to start in a smaller, less pretentious CRO, which, like yourself, has moderate experience in clinical trials. Usually, the clinical research industry is old, and companies discovered 5-10 years ago are considered startups. These companies are most likely to hire newbies, first because they would struggle to afford an experienced CRA salary, and second because they prefer to invest in the people they hire long-term thus it makes sense for them to hire rookies. Therefore, you could start your career with a smaller CRO, still learn a lot, and later on, if you decide to explore more options, you will already have CRA experience on your CV, which will make you a desirable candidate (in combination with your medical degree).

Non-formal education and additional certification

There is a significant amount of information available online regarding the position, how to prepare for the interview, and how to handle CRA responsibilities on the job. Compared to when I was starting out, there are now many more options available. What I would personally recommend is to search for all sorts of job descriptions and characteristics (usually found in every job posting) and then research each one of them. Another thing I have done is to follow and watch every single video on YouTube about CRA's daily life. This will provide estimations on what to expect, your responsibilities as a CRA, and what is expected of you.

Additionally, there are plenty of available post-graduate programs and certifications for future CRAs, including courses and online academies. Here are a few examples:

• The most important requirement is to obtain GCP certification. Good Clinical Practice certification is required for all clinical research professionals working at the clinical site or as a monitor (CRA) for the study. Without it, you cannot be a monitor. Additionally, you need to re-certify yourself every two to three years, depending on your company requirements.

• Dan Sfera, also known as The Clinical Trials Guru, was the first person I started following a long time ago. At the time, he was the only one who spoke about clinical trials and offered additional information about the space. You can find more information about him here.

• Viares: They offer various online certification programs for clinical research professionals, from study coordinators to CRAs. You can find more information at their website.

• CRA Connect: I recently connected with Maria on LinkedIn and was delighted by her passion and dedication for clinical research. It was refreshing to meet someone with similar interests and ideas like me. She launched her CRA Academy, CRAConnect, on March 8th. The academy is not just a platform for online CRA courses but also a vibrant community of over 10,000 followers seeking accessible and engaging education. If you're interested in becoming a CRA, I highly recommend checking out CRAConnect. Here is their website.

• Harvard School of Medicine: They offer the Global Clinical Scholars Research Training program, a research program for clinical professionals. You can find more information at their website.

However, I have never paid for such a course (partly because I was broke in my early 20s), and I believe you could still achieve the same result by doing good research yourself.

Keep in mind that, apart from industry knowledge, as a CRA, you'll need a variety of skill sets to do your daily job, including administrative skills (accurate documentation), IT and computer skills (databases and systems management and those are crucial), written and oral communication skills, keen attention to detail and organization, ability to manage and coordinate with several stakeholders, strong understanding of clinical research trials and healthcare space, and medical terminology. Problem-solving skills are also crucially important, as the majority of the time, you will be the first point of contact for all clinical sites. Lastly, you'll need a driver's license, as you'll be traveling a significant amount of time.

Proactivity is also needed - make sure you have access to all sorts of CRA groups on social media, podcasts, YouTube channels, etc. This will give you plenty of insights on the industry and what's been going on so that when you go to a CRA job interview, at least you'll sound like you know what you're talking about.

Building your own network

Networking - as I mentioned earlier, in order to become an effective CRA, you need to be aware of innovations in your field, and building a network of contacts is crucial. LinkedIn is a great platform for this; you can follow all global pharmaceutical companies and CROs, join relevant CRA groups, and learn a lot about various topics in the healthcare space. You should also build your personal network by connecting with industry professionals who have already built successful careers, people with numerous contacts in their network, and other CRAs from around the world. These connections can be useful when you need them, or at least they could help you get you noticed in the industry. In fact, all Pharma recruiters are on LinkedIn, using it to hunt for new talent and search for suitable profiles for their job postings. So it's important to be active on the platform - comment, like, share, post, and write articles to increase your visibility. The more persistent your involvement, the easier it is to find and connect with new people as this is how the algorithms work.

Attending various types of pharmaceutical events such as conferences, seminars, and summits can also be greatly beneficial (although a bit pricey if you are paying for yourself and not going as a company representative), as they provide the opportunity to meet industry professionals face-to-face, whom you may not have been able to reach otherwise. If you manage selling yourself effectively, you might even leave with an interview invitation or at least a valuable contact.

Expectations

Here I would also like to discuss what you should expect now that you have landed your first CRA job. It is important to understand that everything you have learned so far, including online resources, courses, and podcasts, is just the incredibly small tip of the iceberg. I don't mean to discourage you, but it's important to realize that the CRA job is extremely vast and no course can fully prepare you for it. You will be required to make daily decisions and be responsible for several clinical trials, including their execution and all clinical sites and staff involved in the studies. The ability to think critically is also of great importance, as you will often be the only one familiar with the situation you are dealing with at the moment.

A Clinical Research Associate job requires a lot of traveling across the country, visiting different hospitals and performing various types of visits including selection, initiation, monitoring, closeout, and audit. In general, most companies require approximately 8 days spent on-site visits, considering that the sites could be located anywhere in the country. This may not seem like a lot; however, if you are looking to do that long-term, you should also consider whether you will be comfortable not being at home for at least 2 days per week, with some overnight stays in different hotels. While the dynamic environment can be extremely fun and exciting, especially in your early 20s, you need to also consider whether you would like to have the same lifestyle once you are settled and have started a family.

Apart from that, you can expect to be heavily involved in monitoring patient files, medical records, and all collected patients’ data during the study. You will communicate on a daily basis with project managers, and in some cases, with sponsors (the pharmaceutical company paying for the study being executed), as well as doctors and study coordinators from the sites. Your job will be to ensure that everything concerning the trial is done according to the protocol requirement and FDA or EMA regulations, and, of course, that the PI knows how to reset his password (yes, this falls under your responsibilities as well).

There are definitely some undeniable perks of being a CRA. You get a highly competitive salary, which can range from 70k to 120k annually depending on your level of degree, experience, the company you are working with, and the amount of visits per month. Additionally, many companies offer yearly and performance-based bonuses, car and meal allowances, and 25 days of paid leave. Most monitors work remotely, which is becoming more of an industry standard. The majority of companies offer similar packages with minor differences. Some larger CROs also offer a sign-in bonus.

The job of a monitor is extremely interesting, challenging, and dynamic. However, it's up to you to decide whether you can handle the stress and if you're ready to take on this challenge. It's definitely not for everyone.

As the topic of what to expect once you become a CRA is very broad, I will provide an in-depth review of the daily tasks and responsibilities of a CRA in a separate article. I will also cover how to handle certain situations and share my personal experiences. If you are interested, you can subscribe to my newsletter.

Career growth and opportunities

Career growth and long-term opportunities are important to consider when pursuing a job as a Clinical Research Associate (CRA). Once you have landed your dream job as a CRA, it is essential to think about what comes next. When a CRA reaches the senior level, there are typically three main routes a career in clinical research can take: trial process management, people management, or project management.

It is important to note that titles and positions may vary significantly depending on whether you are working for a Contract Research Organisation (CRO) company (such as IQVIA, PPD, or PSI) or a Sponsor company (such as Pfizer, AstraZeneca, or Novartis).

The career paths for a CRA are as follows:

Clinical Team Management:

A Clinical Team Manager is responsible for acting as the direct line manager to associates. Clinical Team Managers will manage and support team members, ensure staff are trained effectively, review the effectiveness of business processes, and plan professional development activities.

Clinical Project Management:

A Clinical Project Manager is involved in the planning and directing of clinical trials and is also responsible for evaluating clinical data. Day-to-day tasks include maintaining study records, ensuring activities are being delivered on time and on budget, interpreting study data, and developing trial plans.

As there are many career progression paths for a Clinical Research Associate (CRA), I will provide further insights and an in-depth review of what comes next, as well as different career paths that you could pursue in a different article. If you would like to receive notifications for future articles, you can subscribe to my newsletter.